Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Review

Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

Authors: Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou, Samsuridjal Djauzi, Birong Dong, Taro Kojima, Ki Tae Kwon, Hoe Nam Leong, Edward M. F. Leung, Chih-Kuang Liang, Xiaohong Liu, Dilip Mathai, Jiun Yit Pan, Li-Ning Peng, Eduardo Rommel S. Poblete, Philip J. H. Poi, Stewart Reid, Terapong Tantawichien, Chang Won Won

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Herpes zoster (HZ) is a prevalent viral disease that inflicts substantial morbidity and associated healthcare and socioeconomic burdens. Current treatments are not fully effective, especially among the most vulnerable patients. Although widely recommended, vaccination against HZ is not routine; barriers in Asia-Pacific include long-standing neglect of adult immunisation and sparse local data. To address knowledge gaps, raise awareness, and disseminate best practice, we reviewed recent data and guidelines on HZ from the Asia-Pacific region.

Methods

We searched PubMed, Scopus, and World Health Organization databases for articles about HZ published from 1994 to 2014 by authors from Australia, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, New Zealand, the Philippines, Singapore, Taiwan, Thailand, and Vietnam. We selected articles about epidemiology, burden, complications, comorbidities, management, prevention, and recommendations/guidelines. Internet searches retrieved additional HZ immunisation guidelines.

Results

From 4007 retrieved articles, we screened-out 1501 duplicates and excluded 1264 extraneous articles, leaving 1242 unique articles. We found guidelines on adult immunisation from Australia, India, Indonesia, Malaysia, New Zealand, the Philippines, South Korea, and Thailand.
HZ epidemiology in Asia-Pacific is similar to elsewhere; incidence rises with age and peaks at around 70 years – lifetime risk is approximately one-third. Average incidence of 3–10/1000 person-years is rising at around 5% per year. The principal risk factors are immunosenescence and immunosuppression. HZ almost always causes pain, and post-herpetic neuralgia is its most common complication. Half or more of hospitalised HZ patients have post-herpetic neuralgia, secondary infections, or inflammatory sequelae that are occasionally fatal. These disease burdens severely diminish patients’ quality of life and incur heavy healthcare utilisation.

Conclusions

Several countries have abundant data on HZ, but others, especially in South-East Asia, very few. However, Asia-Pacific countries generally lack data on HZ vaccine safety, efficacy and cost-effectiveness. Physicians treating HZ and its complications in Asia-Pacific face familiar challenges but, with a vast aged population, Asia bears a unique and growing burden of disease. Given the strong rationale for prevention, most adult immunisation guidelines include HZ vaccine, yet it remains underused. We urge all stakeholders to give higher priority to adult immunisation in general and HZ in particular.
Appendix
Available only for authorised users
Footnotes
1
Afghanistan, Bangladesh, Bhutan, Brunei, Burma, Cambodia, China, Hong Kong, India, Indonesia, Iran, Japan, Laos, Macau, Malaysia, Maldives, Mongolia, Nepal, North Korea, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Timor-Leste, Vietnam.
 
Literature
1.
Harpaz R, Hales CM, Bialek S. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep. 2011;60:1528.
2.
Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92:593–604.
3.
Isahak I. Steering Committee for Prevention and Control of Infectious Diseases in Asia. Adult immunization—a neglected issue in Southeast Asia. Southeast Asian J Trop Med Public Health. 2000;31:173–84.
4.
Verma R, Khanna P, Chawla S. Vaccines for the elderly need to be introduced into the immunization program in India. Hum Vaccin Immunother. 2014;10:2468–70.
5.
Woodward M. Immunisation of older people. J Pharm Pract Res. 2012;42:316–22.
6.
Wong SY. Adult vaccination update 2014. The Singapore Fam Physician. 2014;40:27–32.
7.
Araújo LQ, MacIntyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes. 2007;14(Suppl 2):40–4.
8.
9.
Thomas J. Herpes zoster: Complications and management. J Pak Assoc Dermatol. 2004;14:237–43.
10.
Harpaz R, Ortega-Saznchez IR, Seward JF. Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1–30.PubMed
11.
Kim YM, Lee SY, Lee JS, Park YL, Whang KU, Cho MK, et al. Epidemiological and clinical study on herpes zoster in the Province of Chungcheongnam-do (2004–2006). Korean J Dermatol. 2008;46:1488–94.
12.
13.
Shukuwa T, Chen WY, Kobayashi A. Statistical analysis of herpes zoster observed at Sasebo City General Hospital. Nishinihon J Dermatol. 2002;64:477–82.CrossRef
14.
Naveen KN, Tophakane RS, Hanumanthayya K, Pv B, Pai VV. A study of HIV seropositivity with various clinical manifestation of herpes zoster among patients from Karnataka, India. Dermatol Online J. 2011;17:3.PubMed
15.
Jara MFA, Roa FC. The clinical presentation of herpes zoster patients and predictors of postherpetic neuralgia: A 5-year retrospective study at the section of dermatology, University of the Philippines - Philippine General Hospital. J Phil Dermatol Soc. 2010;19:8–12.
16.
Leung AYH, Yuen KY, Cheng VCC, Lie AKW, Liang R, Kwong YL. Clinical characteristics of and risk factors for herpes zoster after hematopoietic stem cell transplantation. Haematologica. 2002;87:444–6.PubMed
17.
Reid JS, Ah WB. Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years. N Z Med J. 2014;127:56–60.PubMed
18.
Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol. 1997;36:667–72.PubMedCrossRef
19.
Song JY, Chung BS, Choi KC, Shin BS. A 5-year period clinical observation on herpes zoster and the incidence of postherpetic neuralgia (2002–2006); a comparative analysis with the historical control group of a previous study (1995–1999). Korean J Dermatol. 2008;46:431–6.
20.
Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54:529–36.PubMedCrossRef
21.
Song T. Statistical analysis of 522 cases of patient with herpes-zoster. Med J Wuhan Univ. 2002;23:379–82.
22.
Wallis KA, Hood LJ, Rao K. Herpes zoster: when do patients present and who gets antiviral treatment? J Prim Health Care. 2014;6:108–13.PubMed
23.
Kurokawa I, Kumano K, Murakawa K. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res. 2002;30:56–65.PubMedCrossRef
24.
Kang CI, Choi CM, Hong SS, Kim HB, Kim NJ, Oh MD, et al. The incidence of herpes zoster in otherwise healthy young soldiers of Korean army. Infect Chemother. 2006;38:45–6.
25.
Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30.PubMedCrossRef
26.
Park SY, Kim JY, Kim CD, Kim CW, Lee KS. A clinical study on herpes zoster during the last 10-year-period (1994–2003). Korean J Dermatol. 2004;42:1531–5.
27.
Das AL, Sayal SK, Gupta CM, Chatterjee M. Herpes zoster in patients with HIV infection. Indian J Dermatol Venereol Leprol. 1997;63:101–4.PubMed
28.
Kurokawa I, Murakawa K, Kumano K. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster. Int J Clin Pract. 2007;61:1223–9.PubMedCrossRef
29.
30.
Aunhachoke K, Bussaratid V, Chirachanakul P, Chua-Intra B, Dhitavat J, Jaisathaporn K, et al. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand. Int J Dermatol. 2011;50:428–35.PubMedCrossRef
31.
Achar A, Chakraborty PP, Ghosh T, Naskar B, Guharay T, Bisai S. Clinical efficacy and tolerability of valacyclovir versus acyclovir in treatment of herpes zoster. Iran J Dermatol. 2011;14:52–7.
32.
Kim CG, Na CH, Choi KC, Shin BS. A comparative study of the clinical findings associated with herpes zoster and according to age. Korean J Dermatol. 2009;47:1338–44.
33.
Kim HJ, Sung HC, Kim DW, Lee WJ, Lee SJ, Na GY. Clinical features of herpes zoster according to immune state. Korean J Dermatol. 2006;44:149–56.
34.
35.
Naveen KN, Pradeep AV, Kumar JS, Hegde SP, Pai VV, Athanikar SB. Herpes zoster affecting all three divisions of trigeminal nerve in an immunocompetent male: a rare presentation. Indian J Dermatol. 2014;59:423.
36.
Sangeeta N, Robindro Singh W, Brajach SO. Herpes zoster in a healthy adult: Report of a case with oro-cutaneous presentations. JMS J Med Soc. 2011;25:99–101.
37.
Watanabe K, Funaki M. Images in clinical medicine: Zoster of the tympanic membrane. N Engl J Med. 2011;365:e40.PubMedCrossRef
38.
Hong SB, Lee JW, Chang SG, Lee MH, Haw CR. Herpes zoster of the penis. Korean J Urol. 2005;46:1001–3.
39.
Gopalan V, Nair RG, Pillai S, Oberholzer T. Genital herpes zoster as a consequence of cancer chemotherapy-induced immunosuppression: report of a case. J Infect Chemother. 2012;18:955–7.PubMedCrossRef
40.
Watanabe D, Kuhara T, Ishida N, Takama H, Tamada Y, Matsumoto Y. Herpes zoster of the nipple: rapid DNA-based diagnosis by the loop-mediated isothermal amplification method. Int J STD AIDS. 2010;21:66–7.PubMedCrossRef
41.
Izu K, Yamamoto O, Yasumoto S, Hashimoto T, Sata T, Tokura Y. Herpes zoster occurring as a solitary nodule on the index finger. Br J Dermatol. 2004;150:365–6.PubMedCrossRef
42.
Chen WH, Li TH, Lee LH, Huang CC. Varicella-zoster virus infection and nummular headache: a possible association with epicranial neuralgia. Intern Med. 2012;51:2439–41.PubMedCrossRef
43.
Hon C, Au WY, Cheng VC. Ophthalmic zoster sine herpete presenting as oculomotor palsy after marrow transplantation for acute myeloid leukemia. Haematologica. 2005;90 Suppl 12:EIM04.PubMed
44.
Kim YH, Choi IJ, Kim HM, Ban JH, Cho CH, Ahn JH. Bilateral simultaneous facial nerve palsy: clinical analysis in seven cases. Otol Neurotol. 2008;29:397–400.PubMedCrossRef
45.
Furuta Y, Fukuda S, Suzuki S, Takasu T, Inuyama Y, Nagashima K. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol. 1997;52:316–9.PubMedCrossRef
46.
Fujiwara K, Furuta Y, Fukuda S. A case of associated laryngeal paralysis caused by varicella zoster virus without eruption. Case Rep Med. 2014;2014:916265.PubMedPubMedCentral
47.
Powell KF, Wilson HG, Croxson MC, Marshall MR, Wong EH, Anderson NE, et al. Herpes zoster meningoencephalitis without rash: Varicella zoster virus DNA in CSF. J Neurol Neurosurg Psychiatry. 1995;59:198–9.PubMedPubMedCentralCrossRef
48.
Chen MJ, Chen KH, Chung YM, Li AF, Chou CK, Hsu WM. Detection of varicella-zoster virus DNA in the iris of a zoster sine herpete patient. Int J Biomed Sci. 2006;2:302–4.PubMedPubMedCentral
49.
50.
51.
Mabuchi T, Yamaoka H, Kato M, Ikoma N, Tamiya S, Song HJ, et al. Case of disseminated vesicles of herpes zoster developing one day before the onset of local eruption in a hospitalized immunocompromised patient. Tokai J Exp Clin Med. 2013;38:52–4.PubMed
52.
Kim H, Kang JN, Seol JE, Seo JK, Sung HS. Epidemiology and clinical features of disseminated herpes zoster. Korean J Dermatol. 2013;51:507–12.
53.
Qi X-L, Li C-X, Gao T-W. Herpes zoster generalisatus caused by long-term treatment of cyclosporin: A case report. J Clin Dermatol. 2006;35:313–14.
54.
Park S-H, Lee SY, Yi JH, Choi HS, Yun SK, Kim HU, Ihm CW. A case of herpes zoster duplex unilateralis with herpes zoster generalisatus. Korean J Dermatol. 2005;43:1579–81.
55.
Takaoka Y, Miyachi Y, Yoshikawa Y, Tanioka M, Fujisawa A, Endo Y. Bilateral disseminated herpes zoster in an immunocompetent host. Dermatol Online J. 2013;19:13.PubMed
56.
Gupta LK, Kuldeep CM, Mittal A, Singhal H. Multidermatomal herpes zoster in an immunocompetent female. Indian J Dermatol Venereol Leprol. 2005;71:210–11.PubMedCrossRef
57.
Sun ZH, Guo YY, Li M, Yao ZR. Disseminated herpes zoster in immunocompetent patients not due to varicella-zoster virus gene mutation. Chin Med J. 2013;126:3193.PubMed
58.
Mittal RR. Disseminated herpes zoster. Indian J Dermatol Venereol Leprol. 1995;61:148–9.PubMed
59.
60.
Lee H, Jung HJ, Park MY, Ann JY. Herpes zoster duplex symmetricus in a healthy patient. Korean J Dermatol. 2011;49:1098–101.
61.
Tsai YC, Tsai TF. Herpes zoster duplex bilateralis symmetricus. Dermatol Sin. 2015;33:37–8.CrossRef
62.
63.
Brar BK, Gupta RR, Saghni SS. Bilateral herpes - zoster of widely separated dermatomes in a non-immunocompromised female. Indian J Dermatol Venereol Leprol. 2002;68:48–9.PubMed
64.
Agrawal S, Aara N, Bumb R. Herpes zoster duplex bilateralis symmetricus in an immunocompetent subject. Int J Dermatol. 2014;53:e281–2.PubMedCrossRef
65.
Oh KH, Ahn C, Kim YS, Han JS, Kim S, Lee JS, et al. Atypical generalized zoster with suspicious esophageal involvement and early relapse in an adult renal transplant recepient. Transplant Proc. 2002;34:1174–7.PubMedCrossRef
66.
Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol. 2006;7:13–29.PubMedCrossRef
67.
Kui YP, Hye IL, Ji YK, Kap SL, Seong JS, Chang KH. A case of herpes zoster multiplex in five disparate dermatomes. Korean J Dermatol. 2008;46:973–6.
68.
69.
Ko DH, Park SY, Yoon TJ. A case of bilateral recurrent herpes zoster in multiple myeloma. Korean J Dermatol. 2006;44:1460–3.
70.
Teranishi H, Sakiyama M, Nagatoshi Y, Nomura Y, Inagaki J, Yanai F, et al. Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation. Rinsho Ketsueki. 2011;52:287–92.PubMed
71.
Endoh K, Kawai N, Itoh K, Tominaga K, Kusumoto S, Fukuda M, et al. An autopsy case of non-Hodgkin's lymphoma complicated by fulminant infiltration by disseminated herpes zoster. Jpn J Chemother. 2000;48:75–8.
72.
Ryu DJ, Jung JY, Lee S, Lee JH. A case of herpes zoster duplex bilateralis, a diagnostic clue of human immunodeficiency virus infection. Korean J Dermatol. 2010;48:339–41.
73.
74.
75.
Zhang B, Zhao HX, Lun WH, Sun N, Yang D, Liang HY, et al. Generalized varicella-zoster virus infection: A case report. J Clin Dermatol. 2013;42:595–7.
76.
Chacko S, John TJ, Babu PG, Jacob M, Kaur A, Mathai D. Clinical profile of AIDS in India: a review of 61 cases. J Assoc Physicians India. 1995;43:535–8.PubMed
77.
Higashitake I, Higaki T, Souda N, Yamada H. Recurrent herpes zoster seen in the patient of human immunodeficiency virus infection. Skin Res. 2004;3:216–9.
78.
Kar HK, Gautam RK, Jain RK, Puri P, Doda V. Disseminated cutaneous herpes zoster: A clinical predictor of human immunodeficiency virus infection. Indian J Dermatol Venereol Leprol. 1995;61:40–1.PubMed
79.
Shin BS, Na CH, Song IG, Choi KC. A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol. 2010;22:199–202.PubMedPubMedCentralCrossRef
80.
Kim WJ, Park JW, Shin DH, Choi JS, Kim KH. A case of human immunodeficiency virus infection in recurrent herpes zoster. Korean J Dermatol. 2005;43:271–3.
81.
Kim MS, Choi H, Na CH, Shin BS. A 5-year period clinical study of 16 cases with disseminated herpes zoster (2008–2012). Korean J Dermatol. 2013;51:322–8.
82.
Doki N, Miyawaki S, Tanaka M, Kudo D, Wake A, Oshima K, et al. Visceral varicella zoster virus infection after allogeneic stem cell transplantation. Transpl Infect Dis. 2013;15:314–8.PubMedCrossRef
83.
Saitoh H, Takahashi N, Nanjo H, Kawabata Y, Hirokawa M, Sawada K. Varicella-zoster virus-associated fulminant hepatitis following allogeneic hematopoietic stem cell transplantation for multiple myeloma. Intern Med. 2013;52:1727–30.PubMedCrossRef
84.
Ni XS, Ouyang J, Zhu WH, Wang C, Chen B. Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients. Clin Transplant. 2006;20:485–9.PubMedCrossRef
85.
Ohara F, Kobayashi Y, Akabane D, Maruyama D, Tanimoto K, Kim SW, et al. Abdominal pain and syndrome of inappropriate antidiuretic hormone secretion as a manifestation of visceral varicella zoster virus infection in a patient with non-Hodgkin's lymphoma. Am J Hematol. 2007;82:416.PubMedCrossRef
86.
Yakushijin Y, Minamoto Y, Takada K, Otsuka M, Yasukawa M, Fujita S. A case of fatal varicella zoster infection with refractory abdominal pain as an early symptom. Kansenshogaku Zasshi. 2004;78:64–9.PubMedCrossRef
87.
Au WY, Ma SY, Cheng VC, Ooi CG, Lie AK. Disseminated zoster, hyponatraemia, severe abdominal pain and leukaemia relapse: recognition of a new clinical quartet after bone marrow transplantation. Br J Dermatol. 2003;149:862–5.PubMedCrossRef
88.
Kurtovic J, Webster GJM, Singh-Grewal I, Bullpitt P, Haindl W, Wakefield D, et al. Acalculous cholecystitis, multifocal gastrointestinal infarction and pancreatitis resulting from Varicella-zoster virus. Intern Med J. 2005;35:69–70.PubMedCrossRef
89.
Wang Z, Ye J, Han YH. Acute pancreatitis associated with herpes zoster: Case report and literature review. World J Gastroenterol. 2014;20:18053–6.PubMedPubMedCentral
90.
Okimura H, Muto M, Ichimiya M, Mogami S, Takahata H, Asagami C. A case of herpes zoster associated with colitis. J Dermatol. 1996;23:631–4.PubMedCrossRef
91.
Ching DW. Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis. 1995;54:155.PubMedPubMedCentralCrossRef
92.
Hashizume H, Umayahara T. Acute respiratory distress syndrome due to varicella zoster virus pneumonitis in an immunocompromised patient with herpes zoster. J Dermatol. 2013;40:1064–5.PubMedCrossRef
93.
Nakamura M, Kanazawa M, Yamaguchi K, Akizuki M, Satoh S, Inada S. Pneumonia caused by varicella-zoster virus in a patient with rheumatoid arthritis. Nihon Kyobu Shikkan Gakkai Zasshi. 1996;34:610–5.PubMed
94.
Miyazaki T, Tanabe Y, Iseki M. Treatment and recent topics of postherpetic neuralgia. Japan Med Assoc J. 2005;48:505–10.
95.
Sanford M, Keating GM. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging. 2010;27:159–76.PubMedCrossRef
96.
Cheong C, Lee TJ. Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses. Epidemiol Health. 2014;36:e2014012.PubMedPubMedCentralCrossRef
97.
Higa K, Mori M, Hirata K, Hori K, Manabe H, Dan K. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain. 1997;69:245–53.PubMedCrossRef
98.
Sagong C, Yeo KY, Kim JS, Yu HJ, Kim DH. The relationship among pain, depression, and anxiety in patients with herpes zoster. Korean J Dermatol. 2009;47:403–10.
99.
Decroix J, Partsch H, Gonzalez R, Mobacken H, Goh CL, Walsh JB, et al. Factors influencing pain outcome in herpes zoster: An observational study with valaciclovir. J Eur Acad Dermatol Venereol. 2000;14:23–33.PubMedCrossRef
100.
Noh TW, Park HJ, Kim SH, Kang YS, Lee UH, Park HS. A clinical study of herpes zoster focused on the characteristics of pruritus in herpes zoster. Korean J Dermatol. 2012;50:591–8.
101.
Chant KG, Sullivan EA, Burgess MA, Ferson MJ, Forrest JM, Baird LM, et al. Varicella-zoster virus infection in Australia. Aust N Z J Public Health. 1998;22:413–8.PubMedCrossRef
102.
MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol Infect. 2003;131:675–82.PubMedPubMedCentralCrossRef
103.
Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health. 1998;3:886–90.PubMedCrossRef
104.
Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009;27:520–9.PubMedCrossRef
105.
Dashraath P, Ong ES, Lee VJ. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singapore. 2007;36:636–41.PubMed
106.
Chow VTK. Rapid detection of varicella-zoster viral antibodies by latex agglutination assay: A practical experience for medical and science undergraduates. Biochem Educ. 1998;26:248–51.CrossRef
107.
Fatha N, Ang LW, Goh KT. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore. Int J Infect Dis. 2014;22:73–7.PubMedCrossRef
108.
Juffrie M, Graham RR, Tan RI, Widjaja S, Mulyadi S, Weil J, et al. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia). Southeast Asian J Trop Med Public Health. 2000;31:21–4.PubMed
109.
Sam IC, Tariman H, Chan YF, Bador MK, Yusof MY, Hassan H. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia. Med J Malaysia. 2008;63:429–30.PubMed
110.
Barzaga NG, Roxas JR, Florese RH. Varicella zoster virus prevalence in Metro Manila, Philippines. J Am Med Assoc (SE Asia). 1994;274(Suppl):S633–35.
111.
Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr. 2000;37:714–9.PubMed
112.
Migasena S, Simasathien S, Desakorn V, Phonrat B, Suntharasamai P, Pitisuttitham P, et al. Seroprevalence of varicella-zoster virus antibody in Thailand. Int J Infect Dis. 1997;2:26–30.CrossRef
113.
Bhattarakosol P, Chantarabul S, Pittayathikhun K, Mung-mee V, Punnarugsa V. Prevalence of anti-varicella zoster IgG antibody in undergraduate students. Asian Pac J Allergy Immunol. 1996;14:129–31.PubMed
114.
Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S, Warachit B, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 2001;64:131–6.PubMed
115.
Srichomkwun P, Apisarnthanarak A, Thongphubeth K, Yuekyen C, Mundy LM. Evidence of vaccine protection among Thai medical students and implications for occupational health. Infect Control Hosp Epidemiol. 2009;30:585–8.PubMedCrossRef
116.
Suwanpakdee D, Laohapand C, Moolasart V, Lomtong P, Krairojananan N, Srisawat P, et al. Serosurveillance of varicella and hepatitis B infection after reported cases in medical students and the relationship between past varicella disease history and immunity status. J Med Assoc Thai. 2012;95 Suppl 5:S80–5.PubMed
117.
Kowitdamrong E, Pancharoen C, Thammaborvorn R, Bhattarakosol P. The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months. J Med Assoc Thai. 2005;88 Suppl 4:S7–11.PubMed
118.
O'Grady KA, Merianos A, Patel M, Gilbert L. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate. Trop Med Int Health. 2000;5:732–6.PubMedCrossRef
119.
Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect. 2003;131:1085–9.PubMedPubMedCentralCrossRef
120.
Lin YJ, Huang LM, Lee CY, Chih TW, Lee PL, Chang LY, et al. A seroepidemiological study of Varicella-Zoster virus in Taipei City. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1996;37:11–5.PubMed
121.
Wu MF, Yang YW, Lin WY, Chang CY, Soon MS, Liu CE. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection. J Hosp Infect. 2012;80:162–7.PubMedCrossRef
122.
Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, Ng MH. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol. 1994;43:91–6.PubMedCrossRef
123.
Fung LW, Lao TT, Suen SS, Chan OK, Lau TK, Ngai KL, et al. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history. Vaccine. 2011;29:8186–8.PubMedCrossRef
124.
Liu JJ, Wang ML, Gan L, Liao WJ, Chen J. Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30:371–5.PubMed
125.
Zhou Z, Wang S, Chu Y, Xie G. Survey of seroprevalence of varicella zoster virus in healthy population in Shanghai. Chin J Vaccin Immun. 2006;2:137–9.
126.
Wang Y. Seroepidemiological survey of prevalence of varicella-zoster virus in healthy population in Shenzen City. Chin Trop Med. 2006;7:1166–7.
127.
Pan W, Zhang X, Cai Z, Zhang H. A sero-epidemiological investigation on varicella-zoster virus in healthy people in Fujian. Pract Prev Med. 2003;6:864–5.
128.
Han SB, Kang KR, Huh DH, Lee HC, Kim JH, Kang JH, et al. Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test. Epidemiol Infect. 2015;143:1643–50.PubMedCrossRef
129.
Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea. Int J Infect Dis. 2008;12:245–7.PubMedCrossRef
130.
Choi YJ, Kim KH, Oh MD. Genotype of varicella zoster virus isolated from Korean elderly patients with herpes zoster. Infect Chemother. 2010;42:162–70.CrossRef
131.
132.
Kang JH, Park YS, Park SY, Kim SB, Ko KP, Seo YH. Varicella seroprevalence among health care workers in Korea: validity of self-reported history and cost-effectiveness of prevaccination screening. Am J Infect Control. 2014;42:885–7.PubMedCrossRef
133.
Kim YH, Hwang JY, Lee KM, Choi JH, Lee TY, Choi JS, et al. Seroepidemiologic survey of varicella-zoster virus in Korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen test. Ann Dermatol. 2011;23:39–43.PubMedPubMedCentralCrossRef
134.
Yoshida N, Tsumura N, Toyomasu K, Sagawa K. Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students. Sangyo Eiseigaku Zasshi. 2007;49:21–6.PubMedCrossRef
135.
136.
Lin YH, Huang LM, Chang IS, Tsai FY, Lu CY, Shao PL, et al. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28:1217–20.PubMedCrossRef
137.
Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009;89:612–6.PubMedCrossRef
138.
139.
Toyama N, Shiraki K. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81:2053–8.PubMedCrossRef
140.
Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, et al. Disease burden of herpes zoster in Korea. J Clin Virol. 2010;47:325–9.PubMedCrossRef
141.
142.
Wu CY, Hu HY, Huang N, Pu CY, Shen HC, Chou YJ. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan. J Dermatol. 2010;37:463–70.PubMedCrossRef
143.
Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect. 2012;140:1131–40.PubMedCrossRef
144.
Pongsumpun P. Local stability analysis of age structural model for herpes zoster in Thailand. Int J Math Comput Stat Nat Phys Eng. 2013;7:1146–52.
145.
Nelson MR, Britt HC, Harrison CM. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010;193:110–3.PubMed
146.
147.
Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28:2532–8.PubMedCrossRef
148.
Bak H, Ahn SK. A statistical study of dermatoses (2000–2004). Korean J Dermatol. 2005;43:1192–9.
149.
Lee H-J, Choi SI, Ahn SK. A statistical study of dermatoses in Wonju (2005 ~ 2009). Korean J Dermatol. 2010;48:460–7.
150.
151.
Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: A systematic multidisciplinary review. PLoS One. 2013;8:e66485.
152.
Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: Evidence of increase in incidence in adults attributable to varicella immunization? Epidemiol Infect. 2011;139:658–65.PubMedCrossRef
153.
Jeong SK, Kim IH. Recurrence rate of herpes zoster during the previous decade. Korean J Dermatol. 2012;50:287–9.
154.
Tunsuriyawong S, Puavilai S. Herpes zoster, clinical course and associated diseases: A 5-year retrospective study at Ramathibodi Hospital. J Med Assoc Thai. 2005;88:678–81.PubMed
155.
Ikeda M, Hiroshige K, Abiko Y, Onoda K. Impaired specific cellular immunity to the varicella-zoster virus in patients with herpes zoster oticus. J Laryngol Otol. 1996;110:918–21.PubMedCrossRef
156.
Tang H, Moriishi E, Okamoto S, Okuno Y, Iso H, Asada H, et al. A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol. 2012;55:46–50.PubMedCrossRef
157.
Lin SY, Liu JH, Lin CL, Tsai IJ, Chen PC, Chung CJ, et al. A comparison of herpes zoster incidence across the spectrum of chronic kidney disease, dialysis and transplantation. Am J Nephrol. 2012;36:27–33.PubMedCrossRef
158.
Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection. 2011;39:537–44.PubMedPubMedCentralCrossRef
159.
Kuo CC, Lee CT, Lee IM, Ho SC, Yang CY. Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study. Am J Kidney Dis. 2012;59:428–33.PubMedCrossRef
160.
Wu MY, Hsu YH, Su CL, Lin YF, Lin HW. Risk of herpes zoster in CKD: a matched-cohort study based on administrative data. Am J Kidney Dis. 2012;60:548–52.PubMedCrossRef
161.
Chen HH, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo). 2011;66:1177–82.CrossRef
162.
Tsai SY, Yang TY, Lin CL, Tsai YH, Kuo CF, Kao CH. Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study. Int J Clin Pract. 2015;69:228–34.PubMedCrossRef
163.
Chen JY, Cheng TJ, Chang CY, Lan KM, Weng SF, Sheu MJ, et al. Increased incidence of herpes zoster in adult patients with peptic ulcer disease: A population-based cohort study. Int J Epidemiol. 2013;42:1873–81.PubMedCrossRef
164.
Yang YW, Chen YH, Wang KH, Wang CY, Lin HW. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ. 2011;183:E275–80.PubMedPubMedCentralCrossRef
165.
Umezawa Y, Fukuchi O, Ito T, Saeki H, Nakagawa H. Risk of herpes zoster in psoriatic patients undergoing biologic treatment. J Dermatol. 2014;41:168–70.PubMedCrossRef
166.
Hu SC, Lin CL, Lu YW, Chen GS, Yu HS, Wu CS, et al. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus. Acta Derm Venereol. 2013;93:314–8.PubMedCrossRef
167.
Zou Y, Lin M, Sheng Z, Niu S. Bortezomib and lenalidomide as front-line therapy for multiple myeloma. Leuk Lymphoma. 2014;55:2024–31.PubMedCrossRef
168.
Lyu SM, Byun JY, Choi YW, Choi HY. Clinical features of dermatology-consulted inpatients - Focus on the differences between individual departments. Korean J Dermatol. 2014;52:215–21.
169.
Oh SI, Oh BH, Rho JR, Kim KB, Kim JJ, Song MG, et al. Results of heart transplantation in Korea. Korean J Med. 2001;60:228–33.
170.
Tzeng CH, Liu JH, Fan S, Wang SY, Wang SR, Chen KY, et al. Varicella zoster virus infection after allogeneic or autologous hemopoietic stem cell transplantation. J Formos Med Assoc. 1995;94:313–7.PubMed
171.
Nakasone H, Izutsu K, Wakita S, Yamaguchi H, Muramatsu-Kida M, Usuki K. Autologous stem cell transplantation with PCR-negative graft would be associated with a favorable outcome in core-binding factor acute myeloid leukemia. Biol Blood Marrow Transplant. 2008;14:1262–9.PubMedCrossRef
172.
Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis. 2006;65:508–14.PubMedCrossRef
173.
Jiang Z, Xiao H, Pang Y, Xiao Y. The incidence of herpes zoster after hematopoietic stem cell transplantation. Chin J Infect Chemother. 2012;12:88–91.
174.
Chugh KS, Sharma SC, Singh V, Sakhuja V, Jha V, Gupta KL. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment. Dermatology. 1994;188:108–12.PubMedCrossRef
175.
Prakash J, Singh S, Prashant GK, Kar B, Tripathi K, Singh PB. Mucocutaneous lesions in transplant recipient in a tropical country. Transplant Proc. 2004;36:2162–4.PubMedCrossRef
176.
Hwang EA, Kang MJ, Han SY, Park SB, Kim HC. Viral infection following kidney transplantation: long-term follow-up in a single center. Transplant Proc. 2004;36:2118–9.PubMedCrossRef
177.
Ko GB, Kim T, Kim SH, Choi SH, Kim YS, Woo JH, et al. Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation. Transpl Infect Dis. 2013;15:416–23.PubMedCrossRef
178.
179.
Ng P, McCluskey P, McCaughan G, Glanville A, MacDonald P, Keogh A. Ocular complications of heart, lung, and liver transplantation. Br J Ophthalmol. 1998;82:423–8.PubMedPubMedCentralCrossRef
180.
Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, et al. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol. 2004;15:809–17.PubMedCrossRef
181.
Tomonari A, Iseki T, Takahashi S, Ooi J, Takasugi K, Shimohakamada Y, et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol. 2003;122:802–5.PubMedCrossRef
182.
Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, et al. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant. 2009;15:724–9.PubMedCrossRef
183.
Wu M, Huang F, Jiang X, Fan Z, Zhou H, Liu C, et al. Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. PLoS One. 2013;8:e77805.PubMedPubMedCentralCrossRef
184.
Suzuki J, Ashizawa M, Okuda S, Wada H, Sakamoto K, Terasako K, et al. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2012;14:E7–12.PubMedCrossRef
185.
Au WY, Hon C, Cheng VCC, Ma ESK. Concomitant zoster myelitis and cerebral leukemia relapse after stem cell transplantation. Ann Hematol. 2005;84:59–60.PubMedCrossRef
186.
Fukuno K, Tomonari A, Takahashi S, Ooi J, Takasugi K, Tsukada N, et al. Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia. Int J Hematol. 2006;84:79–82.PubMedCrossRef
187.
Kang EH, Chung MP, Kang SJ, An CH, Ahn JW, Han J, Lee. Clinical features and treatment response in 18 cases with idiopathic nonspecific interstitial pneumonia. Tuberc Respir Dis. 2000;48:530–41.CrossRef
188.
Ozono Y, Harada T, Yamaguchi K, Taura K, Hara K, Taguchi T. Nephrotic syndrome in the elderly–clinicopathological study. Nihon Jinzo Gakkai Shi. 1994;36:44–50.PubMed
189.
Satoh N, Abe T, Nakajima A, Sakuragi S. Recurrent varicella-zoster virus retinitis in a patient treated with systemic corticosteroids. Ocul Immunol Inflamm. 1998;6:185–8.PubMedCrossRef
190.
Xiao X, Lu Y, Su H, Zhong K, Chen X, Da Y, et al. Clinical features and treatment of angioimmunoblastic T-cell lymphoma. Chin J Clin Oncol. 2011;38:1103–6.
191.
Usami E, Kimura M, Matsuoka T, Okada K, Nakao T, Yoshimura T, et al. The frequency and risk factor of herpes zoster infection in non-Hodgkin's lymphoma patients. Jpn J Cancer Chemother. 2011;38:243–7.
192.
Mills AK, Taylor KM, Wright SJ, Bunce LH, Bashford J, White K, et al. Sustained responses following alternating chlorodeoxyadenosine (2CDA) and VAC regimen in poor-risk de-novo follicular non-hodgkin's lymphoma (NHL). In: Blood 2000;96(11) Part II: The 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, WA, 25–28 July 2000. p. 243b.
193.
Au WY, Kwong YL. Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge. J Am Acad Dermatol. 2005;53:890–2.PubMedCrossRef
194.
Zhang Q, Mu LJ, Wang XB, Li L, Kang ZJ, Yan JS. Clinical analysis of hematologic disorders complicated with herpes zoster after treating with arsenic trioxide. J Leuk Lymphoma. 2011;20:412–4.
195.
Yamakura M, Tsuda K, Ugai T, Sugihara H, Nisihida Y, Takeuchi M, et al. High frequency of varicella zoster virus reactivation associated with the use of arsenic trioxide in patients with acute promyelocytic leukemia. Acta Haematol. 2014;131:76–7.PubMedCrossRef
196.
Au WY, Kumana CR, Lee HK, Lin SY, Liu H, Yeung DY, et al. Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. Blood. 2011;118:6535–43.PubMedCrossRef
197.
Chan AYK, Hooi LS. Outcome of 85 lupus nephritis patients treated with intravenous clophosphamide: A single centre 10 year experience. Med J Malays. 2000;55:14–20.
198.
Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone. Nephron. 1995;71:321–7.PubMedCrossRef
199.
Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, et al. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus. 1999;8:545–51.PubMedCrossRef
200.
Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, et al. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens. Am J Kidney Dis. 2001;38:256–64.PubMedCrossRef
201.
Liu G, Chen Y, Zuo C, Xie Q, Wang Z, Wang L, et al. Study on bolus cyclosphamide treatment for 64 cases of lupus nephritis. J West China Univ Med Sci. 2001;32:129–130,139.
202.
Mok CC, Ying KY, Mak A, To CH, Szeto ML. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine. Rheumatology (Oxford). 2006;45:425–9.CrossRef
203.
Kim JH, Cheon JH, Kim WH. The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease. Korean J Gastroenterol. 2008;51:291–7.PubMed
204.
Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005;24:517–25.PubMedCrossRef
205.
Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, et al. Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus. 2011;20:1484–93.PubMedCrossRef
206.
Hu W, Liu C, Xie H, Chen H, Liu Z, Li L. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant. 2008;23:1307–12.PubMedCrossRef
207.
Kim YS, Moon JI, Kim SI, Park K. Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations. Transplantation. 1999;68:578–81.PubMedCrossRef
208.
Lu F, Tu Y, Peng X, Wang L, Wang H, Sun Z, et al. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. Lupus. 2008;17:622–9.CrossRef
209.
Hegde S, Annamalai R, Biswas J. Extensive herpes zoster involvement following mycophenolate mofetil therapy for sarcoidosis. J Ophthalmic Inflamm Infect. 2012;2:47–8.PubMedCrossRef
210.
Satoh S, Tada H, Murakami M, Tsuchiya N, Inoue T, Togashi H, et al. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation. Transplant Proc. 2005;37:1751–3.PubMedCrossRef
211.
Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, et al. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome. Nephrology (Carlton). 2012;17:352–7.CrossRef
212.
Mak SK, Lo KY, Lo MW, Chan SF, Tong GM, Wong PN, et al. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis. Nephrology (Carlton). 2008;13:331–6.CrossRef
213.
Li L, Wang H, Lin S, et al. Mycophenolate mofetil treatment for diffuse proliferative lupus nephritis: a multicenter clinical trial in China. Zhonghua Nei Ke Za Zhi. 2002;41:476–9.PubMed
214.
Xie QX, Han CX, Li JY, Lin XC, Zhao L, Huang HW, et al. Application of low-dosage mycophenolate mofetil in living renal transplantation of lineal consanguinity. J Clin Rehab Tissue Eng Res. 2009;13:924–6.
215.
Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT. Leflunomide-associated infections in rheumatoid arthritis. J Rheumatol. 2007;34:2201–3.PubMed
216.
Yoo HG, Yu HM, Jun JB, Jeon HS, Yoo WH. Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide. Mod Rheumatol. 2013;23:709–15.PubMedCrossRef
217.
Cui TG, Hou FF, Ni ZH, Chen XM, Zhang FS, Zhu TY, et al. Treatment of proliferative lupus nephritis with leflunomide and steroid: a prospective multi-center controlled clinical trial. Zhonghua Nei Ke Za Zhi. 2005;44:672–6.PubMed
218.
Muir VJ, Plosker GL. Cladribine tablets: in relapsing-remitting multiple sclerosis. CNS Drugs. 2011;25:239–49.PubMedCrossRef
219.
Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, et al. Non-bacterial infections in Asian patients treated with alemtuzumab: A retrospective study of the Asian Lymphoma Study Group. Leuk Lymphoma. 2012;53:1515–24.PubMedCrossRef
220.
Chung BH, Kim Y, Jeong HS, Hong YA, Choi BS, Park CW, et al. Clinical outcome in patients with chronic antibody-mediated rejection treated with and without rituximab and intravenous immunoglobulin combination therapy. Transpl Immunol. 2014;31:140–4.PubMedCrossRef
221.
Ito K, Okamoto M, Maruyama F, Handa K, Yamamoto Y, Watanabe M, et al. Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster. Gan To Kagaku Ryoho. 2010;37:99–102.PubMed
222.
Kurokawa T, Hase M, Tokuman N, Yoshida T. Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab. Hematol Oncol. 2011;29:5–9.PubMedCrossRef
223.
Lee SD, Kim SH, Kong SY, Kim YK, Lee SA, Park SJ. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. HPB (Oxford). 2014;16:807–13.CrossRef
224.
Tu MF, Zheng W, Lin NJ, Zhang YT, Wang XP, Song YQ, et al. Efficacy and safety of fludarabine-based combination chemotherapy in patients with previously untreated follicular non-Hodgkin's lymphoma. Tumor. 2011;31:58–63.
225.
Furie R, Nicholls K, Cheng TT, Houssiau F, Burgos-Vargas R, Chen SL, et al. Efficacy and safety of abatacept in lupus nephritis: A twelve-month, randomized, double-blind study. Arthritis Rheum. 2014;66:379–89.CrossRef
226.
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, et al. Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med. 2014;370:2377–86.PubMedCrossRef
227.
Winthrop KL, Yamanaka H, Valdez H, Mortensen E, Chew R, Krishnaswami S, et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2014;66:2675–84.CrossRef
228.
Wang X, Zhao J, Zhu S, Xia B. Herpes zoster in Crohn's disease during treatment with infliximab. Eur J Gastroenterol Hepatol. 2014;26:237–9.PubMedCrossRef
229.
Choi KD, Song HJ, Kim JS, Jung HC, Song IS. Efficacy and safety of treatment with infliximab in Crohn's disease-the experience of single center in Korea. Korean J Gastroenterol. 2005;46:48–55.PubMed
230.
Kim YJ, Kim JW, Lee CK, Park HJ, Shim JJ, Jang JY, et al. Clinical outcome of treatment with infliximab in Crohn's disease: a single-center experience. Korean J Gastroenterol. 2013;61:270–8.PubMedCrossRef
231.
Yi YS, Chung JS, Song MK, Shin HJ, Seol YM, Choi YJ, et al. The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma. Korean J Hematol. 2010;45:188–92.PubMedPubMedCentralCrossRef
232.
Kim SJ, Kim K, Kim BS, Lee HJ, Kim H, Lee NR, et al. Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma. Clin Lymphoma Myeloma. 2008;8:237–40.PubMedCrossRef
233.
Kim MG, Kim YJ, Kwon HY, Park HC, Koo TY, Jeong JC, et al. Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation. Nephrology (Carlton). 2013;18:820–6.CrossRef
234.
Tong Y, Qian J, Li Y, Meng H, Jin J. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients. Am J Hematol. 2007;82:403–4.PubMedCrossRef
235.
Zhong YP, Chen SL, Li X, Hu Y, Zhang JJ. Bortezomib combined with other drugs for treating 60 cases of multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17:214–7.PubMed
236.
Khalafallah AA, Woodgate M, Koshy K, Patrick A. Ophthalmic manifestations of herpes zoster virus in patients with multiple myeloma following bone marrow transplantation. BMJ Case Rep. 2013; doi:10.​1136/​bcr-2012-007625.
237.
Zhang YQ, Liang R, Bai QX, Zhang T, Yang L, Wang YW, et al. PAD regimen for relapsed or refractory patients with multiple myeloma. Zhonghua Xue Ye Xue Za Zhi. 2009;30:260–3.PubMed
238.
Muta T, Nakanishi H, Yasunaga M, Senba S, Murakami H, Kan S, et al. Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure. Jpn J Cancer Chemother. 2011;38:237–41.
239.
Li CM, Lu H, Wu HX, Qiu HX, Qian SX, Xu W, et al. Therapeutic efficacy of bortezomib-based chemotherapy on 40 patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18:1511–4.PubMed
240.
Yang G, Chen W, Wu Y. Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment. Chin J Cancer Res. 2013;25:155–60.PubMedPubMedCentral
241.
He J, Yang L, Han X, Zheng G, Zheng W, Wei G, et al. The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma. PLoS One. 2014;9:e99174.PubMedPubMedCentralCrossRef
242.
Huang B, Li J, Xu X, Zheng D, Zhou Z, Liu J. Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD). Pathol Biol (Paris). 2015;63:17–20.CrossRef
243.
Zhang Y, Shi B, Chen X, Xia Y, Ye L, Liu L, et al. Bortezomib combined with doxorubicin and dexamethasone for patients with refractory senile mantle cell lymphoma. Chin J Clin Oncol. 2011;38:1092–4.
244.
Zhong YP, Chen SL. Effect of treatment by bortezomib with other drugs for the refractory multiple myeloma. J Leuk Lymphoma. 2009;18:538–40.
245.
Zhu JJ, Li L, Ye XJ, He JS, Cai Z. Bortezomib combined with epirubicin and dexamethasone in treatment of multiple myeloma. J Pract Oncol. 2013;28:520–2.
246.
Ohguchi H, Sugawara T, Ishikawa I, Okuda M, Tomiya Y, Yamamoto J, et al. A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: beta2-microglobulin associated with time to progression. Int J Hematol. 2009;89:342–7.PubMedCrossRef
247.
Coiffier B, Osmanov EA, Hong X, Scheliga A, Mayer J, Offner F, et al. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. Lancet Oncol. 2011;12:773–84.PubMedCrossRef
248.
Yang GZ, Chen WM, Shen M, Fu LN, Jiang L, Gao W, et al. Sequential therapy of BTD and MPT regimen for the newly-diagnosed multiple myeloma patients no eligible for bone marrow transplantation. J Leuk Lymphoma. 2011;20:350–2.
249.
Zhai YP, Liu HN, Yu YP, Zhou XG, Song P, Li F, et al. Treatment of primary systemic amyloidosis with the combination of bortezomib and dexamethasone. Zhonghua Xue Ye Xue Za Zhi. 2010;31:319–22.PubMed
250.
Gu HT, Shu MM, Gao GX, Dong BX, Liang R, Yang L, et al. Efficacy comparison between standard and reduced doses of bortezomib combined with adriamycin and dexamethasone in the treatment of patients with multiple myeloma. Zhonghua Xue Ye Xue Za Zhi. 2013;34:622–5.PubMed
251.
Zhao Y, Dou LP, Wang SH, Bo J, Wang QS, Huang WR, et al. The efficacy and safety of PAD and VAD regimens for untreated multiple myeloma. Zhonghua Nei Ke Za Zhi. 2010;49:762–4.PubMed
252.
253.
Sachdeva S, Prasher P. Herpes zoster following saphenous venectomy for coronary bypass surgery. J Card Surg. 2010;25:28–9.PubMedCrossRef
254.
Basavaraj S, Prakash BG, Shetty TS, Sandhya D, Kallada S. Delayed facial nerve weakness after intact canal wall tympanomastoidectomy. Otol Neurotol. 2014;35:1003–6.PubMedCrossRef
255.
256.
Brandon EL, Akers J, Rapeport D. Development of bilateral herpes zoster following thoracoscopic splanchnicectomy. Anaesth Intensive Care. 2006;34:382–3.PubMed
257.
Park KS, Yoon TR, Kim SK, Park HW, Song EK. Acute postoperative herpes zoster with a sciatic nerve distribution after total joint arthroplasty of the ipsilateral hip and contralateral knee. J Arthroplasty. 2010;25:497. e11-5.PubMed
258.
Choi HJ, Kim JH, Lee YM. Herpes zoster developing within recent subciliary incision scar. J Craniofac Surg. 2012;23:930–1.PubMedCrossRef
259.
Lin KC, Wang CC, Wang KY, Liao YC, Kuo JR. Reactivation of herpes zoster along the trigeminal nerve with intractable pain after facial trauma: a case report and literature review. BMJ Case Rep. 2009; doi:10.​1136/​bcr.​07.​2008.​0525.
260.
Furuta Y, Ohtani F, Fukuda S, Inuyama Y, Nagashima K. Reactivation of varicella-zoster virus in delayed facial palsy after dental treatment and oro-facial surgery. J Med Virol. 2000;62:42–5.PubMedCrossRef
261.
Furukawa K, Sakoh M, Kumon Y, Teraoka M, Ohta S, Ohue S, et al. Delayed facial palsy after microvascular decompression for hemifacial spasm due to reactivation of varicella-zoster virus. No Shinkei Geka. 2003;31:899–902.PubMed
262.
Baba T, Yamasaki A, Miyake A, Funakoshi T, Yakura K, Miyazaki D, et al. Varicella zoster virus iridocyclitis following macular hole surgery in a case of von Hippel-Lindau disease. Jpn J Clin Ophthalmol. 2011;65:333–7.
263.
Fujitani A, Hayasaka S. Herpes zoster ophthalmicus after cataract surgery in a patient with a history of gastric cancer. Ann Ophthalmol Glaucoma. 1997;29:57–8.
264.
Koide C. Multiple cranial nerve dysfunction after uncomplicated neurovascular decompression for hemifacial spasm. Otolaryngol Head Neck Surg Tokyo. 1997;69:72–5.
265.
Tsukahara T, Huang J, Oyamada T, Uchio E. Herpetic corneal endotheliitis in a case after deep lamellar keratoplasty for bacterial keratitis. Jpn J Clin Ophthalmol. 2010;64:1287–91.
266.
Gyo K, Honda N. Delayed facial palsy after middle-ear surgery due to reactivation of varicella-zoster virus. J Laryngol Otol. 1999;113:914–5.PubMedCrossRef
267.
Kohjitani A, Miyawaki T, Kasuya K, Shimada M. Sympathetic activity-mediated neuropathic facial pain following simple tooth extraction: a case report. Cranio. 2002;20:135–8.PubMedCrossRef
268.
Walland MJ. Presumed ophthalmic Herpes zoster after contralateral cataract extraction. Acta Ophthalmol Scand. 1995;73:83–5.PubMedCrossRef
269.
Kam AC, Dan NG, Maclean J, Higgins D. Zoster related multiple cranial nerve palsies: an unusual complication following percutaneous balloon compression for trigeminal neuralgia. J Clin Neurosci. 1999;6:261–4.PubMedCrossRef
270.
Makkar JK, Singh NP, Rastogi V. Herpes zoster: Are selective nerve root injections the treatment or the cause? Pain Phys. 2010;13:196–8.
271.
Oh IH, Choi SK, Park BJ, Kim TS, Rhee BA, Lim YJ. The treatment outcome of elderly patients with idiopathic trigeminal neuralgia : Micro-vascular decompression versus gamma knife radiosurgery. J Korean Neurosurg Soc. 2008;44:199–204.PubMedPubMedCentralCrossRef
272.
Chen YH, Rau RH, Keller JJ, Lin HC. Possible effects of anaesthetic management on the 1 yr followed-up risk of herpes zoster after Caesarean deliveries. Br J Anaesth. 2012;108:278–82.PubMedCrossRef
273.
Terao M, Yamamoto T, Umeda J, Shirabe H. Drug induced herpes zoster (Do statin induce herpes zoster?). Skin Res. 2005;4:335–8.
274.
Chung SD, Tsai MC, Liu SP, Lin HC, Kang JH. Herpes zoster is associated with prior statin use: a population-based case–control study. PLoS One. 2014;9:e111268.PubMedPubMedCentralCrossRef
275.
Kano Y, Horie C, Inaoka M, Tadashi I, Mizukawa Y, Shiohara T. Herpes zoster in patients with drug-induced hypersensitivity syndrome/DRESS. Acta Derm-Venereol. 2012;92:206–7.PubMedCrossRef
276.
Follezou JY, Lan NY, Lien TX, Lafon ME, Tram LT, Hung PV, et al. Clinical and biological characteristics of human immunodeficiency virus- infected and uninfected intravascular drug users in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg. 1999;61:420–4.PubMed
277.
Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore. 1995;24:528–33.PubMed
278.
Supanaranond W, Desakorn V, Sitakalin C, Naing N, Chirachankul P. Cutaneous manifestations in HIV positive patients. Southeast Asian J Trop Med Public Health. 2001;32:171–6.PubMed
279.
Li ZH, Hua YH. Clinical analysis of skin and mucosa manifestations in 130 patients with HIV. J Clin Dermatol. 2013;42:720–2.
280.
Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int J Dermatol. 2004;43:265–8.PubMedCrossRef
281.
Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS. 2003;17:2129–31.PubMedCrossRef
282.
Tzung TY, Yang CY, Chao SC, Lee JY. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan. Kaohsiung J Med Sci. 2004;20:216–24.PubMedCrossRef
283.
Dwiyana RF, Rowawi R, Lestari M, Alisjahbana B, van der Ven AJ, Djajakusumah TS. Skin disorders in HIV-infected patients from West Java. Acta Med Indones. 2009;41 Suppl 1:18–22.PubMed
284.
Wong KH, Lee SS, Lo YC, Li PC, Ho HF, Sitt WH, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Zhonghua Yi Xue Za Zhi (Taipei). 1995;55:127–36.
285.
Huang XJ, Li HY, Chen DX, Wang XC, Li ZC, Wu YS, et al. Clinical analysis of skin lesions in 796 Chinese HIV- positive patients. Acta Derm Venereol. 2011;91:552–6.PubMedCrossRef
286.
Chen XC, Lu XJ, Ye H, Gao YY. Clinical analysis of 109 HIV/AIDS patients. Chin J Infect Chemother. 2008;8:183–6.
287.
Oh MD, Park SW, Kim HB, Kim US, Kim NJ, Choi HJ, et al. Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis. 1999;29:1524–8.PubMedCrossRef
288.
Wani KA. Clinical profile of HIV/Aids patients in Srinagar, Kashmir, India. Int J Collab Res Intern Med Public Health. 2012;4:1703–12.
289.
Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, et al. Neurological Manifestations of HIV Disease. J Assoc Physicians India. 2001;49:343–8.PubMed
290.
Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol. 2004;70:82–6.PubMed
291.
Arora U, Chopra S, Jindal N. HIV infection in families in and around Amritsar. J Indian Acad Clin Med. 2008;9:184–7.
292.
Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis. 2009;13:e1–8.PubMedCrossRef
293.
Solomon SS, Hawcroft CS, Narasimhan P, Subbaraman R, Srikrishnan AK, Cecelia AJ, et al. Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res. 2008;127:447–52.PubMed
294.
Jindal N, Aggarwal A, Kaur S. HIV seroprevalence and HIV associated dermatoses among patients presenting with skin and mucocutaneous disorders. Indian J Dermatol Venereol Leprol. 2009;75:283–6.PubMedCrossRef
295.
Kar HK, Narayan R, Gautam RK, Jain RK, Doda V, Sengupta D, et al. Mucocutaneous disorders in Hiv positive patients. Indian J Dermatol Venereol Leprol. 1996;62:283–5.PubMed
296.
Srirangaraj S, Venkatesha D. Opportunistic infections in relation to antiretroviral status among AIDS patients from south India. Indian J Med Microbiol. 2011;29:395–400.PubMedCrossRef
297.
Shahapur PR, Bidri RC. Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India. J Nat Sci Biol Med. 2014;5:392–6.PubMedPubMedCentralCrossRef
298.
Song JY, Lee JS, Jung HW, Choi HJ, Lee JS, Eom JS, et al. Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study. J Acquired Immune Defic Syndr. 2010;53:417–9.CrossRef
299.
Kim JM, Cho GJ, Hong SK, Chung JS, Jang KH, Kim CO, et al. Epidemiologic and clinical features of HIV infection/AIDS in Koreans. Korean J Med. 2001;61:355–64.CrossRef
300.
Nam TS, Seo KS, Lee KI, Kim YS, Hong JH, Kim GH, et al. The clinical study of hematoimmunologic features and opportunistic infections of patients with AIDS. Korean J Med. 1997;52:15–23.
301.
Choe KW, Oh MD, Park SW, Kim HB, Kim US, Kang SW, et al. Opportunistic infections and malignancies in 173 patients with HIV infection. Korean J Infect Dis. 1998;30:507–15.
302.
McNulty A, Li Y, Radtke U, Kaldor J, Rohrsheim R, Cooper DA, Donovan B. Herpes zoster and the stage and prognosis of HIV-1 infection. Genitourin Med. 1997;73:467–70.PubMedPubMedCentral
303.
Hung CC, Hsiao CF, Wang JL, Chen MY, Hsieh SM, Sheng WH, et al. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS. 2005;16:673–6.PubMedCrossRef
304.
Chopra S, Arora U. Skin and mucocutaneous manifestations: Useful clinical predictors of HIV/AIDS. J Clin Diagn Res. 2012;6:1695–8.PubMedPubMedCentral
305.
Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Indian J Sex Transm Dis. 2013;34:19–24.PubMedPubMedCentralCrossRef
306.
Mali RJ, Wankhade AB, Ghadage DP, Muley VA, Bhore AV. Cutaneous manifestations in HIV infected patients in rural area. J Pure Appl Microbiol. 2012;6:467–70.
307.
Panda S, Sarkar S, Mandal BK, Singh TB, Singh KL, Mitra DK, et al. Epidemic of herpes zoster following HIV epidemic in Manipur, India. J Infect. 1994;28:167–73.PubMedCrossRef
308.
Panda S, Kamei G, Pamei M, Sarkar S, Sarkar K, Singh ND, et al. Clinical features of HIV infection in drug users of Manipur. Natl Med J India. 1994;7:267–9.PubMed
309.
Antwal M, Gurjar R, Chidrawar S, Pawar J, Gaikwad S, Panchal N, et al. Clinical profile of HIV infected patients attending a HIV referral clinic in Pune. India Indian J Med Res. 2014;140:271–7.PubMed
310.
311.
Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989–96). Indian J Med Res. 2000;111:14–23.PubMed
312.
Srikanth KP, Vijayakumar S, Aparna, Mallikarjun. A hospital based cross sectional study of mucocutaneous manifestations in the HIV infected. Int J Collab Res Intern Med Public Health. 2010;2:50–78.
313.
Fernandes MS, Bhat RM. Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count. Int J STD AIDS. 2015;26:414–9.PubMedCrossRef
314.
Singh HR, Singh NG, Singh TB. Estimation of CD4+ and CD8+ T-lymphocytes in human immunodeficiency virus infection and acquired immunodeficiency syndrome patients in Manipur. Indian J Med Microbiol. 2007;25:126–32.PubMedCrossRef
315.
Price P, Murdoch DM, Agarwal U, Lewin SR, Elliott JH, French MA. Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev. 2009;22:651–63.PubMedPubMedCentralCrossRef
316.
Choi WR, Seo MC, Sung KU, Lee HE, Yoon HJ. Herpes zoster immune reconstitution inflammatory syndrome in a HIV-infected patient: Case report and literature review. Infect Chemother. 2012;44:391–4.CrossRef
317.
Handa S, Narang T, Wanchu A. Dermatologic immune restoration syndrome: report of five cases from a tertiary care center in north India. J Cutan Med Surg. 2008;12:126–32.PubMedCrossRef
318.
Sharma A, Makrandi S, Modi M, Sharma A, Marfatia Y. Immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol. 2008;74:619–21.PubMedCrossRef
319.
Terada K, Yoshihiro K, Kawano S, Morita T. Incidence of herpes zoster in pediatricians and family practitioners Estimation of efficacy of varicella vaccine for protection against herpes zoster in the elderly. Kawasaki Med J. 1994;20:99–102.
320.
Mittal RR. Infectivity of varicella and herpes zoster. Indian J Dermatol Venereol Leprol. 1996;62:196–7.PubMed
321.
Chandak SO, Pandilwar PK. Epidemic of herpes zoster in a family. J Oral Maxillofacial Surg Med Pathol. 2012;24:42–4.CrossRef
322.
Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis. 2004;189:1009–12.PubMedCrossRef
323.
Suzuki K, Yoshikawa T, Tomitaka A, Suzuki K, Matsunaga K, Asano Y. Detection of varicella-zoster virus DNA in throat swabs of patients with herpes zoster and on air purifier filters. J Med Virol. 2002;66:567–70.PubMedCrossRef
324.
Yoshikawa T, Ihira M, Suzuki K, Suga S, Tomitaka A, Ueda H, et al. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol. 2001;63:64–6.PubMedCrossRef
325.
Zhai JX, Ji J, Li M. Cutaneous tuberculosis complicated with squamous cell carcinoma. J Clin Dermatol. 2010;39:713–5.
326.
Kansal HM, Goel S. Cutaneous manifestations in cases of pulmonary tuberculosis: A clinical profile. J Indian Acad Clin Med. 2013;14:284–6.
327.
328.
Regunath H, Shivashankara KN, Sundeep KB, Bhaskar AP. Reactivation of Herpes zoster in an adult with Plasmodium infection. J Vector Borne Dis. 2008;45:251–3.PubMed
329.
Park B, Yun SJ, Lee JB, Lee SC, Won YH, Kim SJ. Analysis of dermatoses in pregnant patients. Korean J Dermatol. 2013;51:249–57.
330.
Kim WJ, Kim JY, Lee WJ, Lee SJ, Kim DW, Ko HC, et al. Investigation of the clinical manifestations of herpes zoster during pregnancy and its impact on the perinatal outcome. Korean J Dermatol. 2010;48:941–7.
331.
Thami GP, Kanwar AJ. Herpes zoster during pregnancy near term: to treat or not to treat? Aust N Z J Obstet Gynaecol. 1999;39:371.PubMedCrossRef
332.
Tsai YG, Lai JH, Kuo SY, Chen HC, Chang DM. Thymoma and hypogammaglobulinemia (Good’s syndrome): a case report. J Microbiol Immunol Infect. 2005;38:218–20.PubMed
333.
Chen JY, Chang CY, Lin YS, Hu ML. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination. Popul Health Manag. 2012;15:391–7.PubMedCrossRef
334.
Chao CT, Lee SY, Yang WS, Yen CJ, Chiang CK, Huang JW, et al. Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients. Sci Rep. 2014;4:7371.PubMedCrossRef
335.
Chao CT, Lai CF, Huang JW. Risk factors for herpes zoster reactivation in maintenance hemodialysis patients. Eur J Intern Med. 2012;23:711–5.PubMedCrossRef
336.
Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, et al. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121:1357–66.PubMedCrossRef
337.
Cho JW, Shin DH, Lee KS. Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster in Korea. J Dermatol Sci. 2007;45:213–5.PubMedCrossRef
338.
Park SJ, Cho JW, Lee KS. Single nucleotide polymorphisms of interleukin-10 promoter gene in Korean herpes zoster patients. Korean J Dermatol. 2006;44:1325–31.
339.
Yuan LL, Wang LX, Xie YM, Yang W, Yang ZX, Zhuang Y, et al. Analysis on clinical features and treatment of herpes zoster patients hospitalized in real world. Zhongguo Zhongyao Zazhi. 2014;39:3469–73.PubMed
340.
Oh HM, Ho AY, Chew SK, Monteiro EH. Clinical presentation of herpes zoster in a Singapore hospital. Singapore Med J. 1997;38:471–4.PubMed
341.
Vikrant S. Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single center from north India. Perit Dial Int. 2014;34:426–33.PubMedPubMedCentralCrossRef
342.
Sato T, Inoue T, Endo K, Watanabe Y, Kikuta T, Tsuda M, et al. End-stage renal disease (ESRD) contributes to the increasing prevalence of herpes zoster. NDT Plus. 2009;2:263–4.PubMedPubMedCentral
343.
Muraya Y. Clinical and immunological evaluation of infection in patients on hemodialysis. J Infect Chemother. 1996;2:247–53.CrossRef
344.
Iwamoto M, Kamimura T, Nagashima T, Kamata Y, Aoki Y, Onishi S, et al. Healthcare-associated infections in rheumatology in Japan. Rheumatol Int. 2012;32:801–4.PubMedCrossRef
345.
Nishimaki T, Watanabe K, Satho Y, Okubo M, Kaise S, Miyata M, et al. Viral, fungal and mycobacterial infections in patients with systemic lupus erythematosus. Jpn J Rheumatol. 1999;9:45–54.
346.
Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 1999;24:327–8.PubMedCrossRef
347.
Naganuma M, Kunisaki R, Yoshimura N, Takeuchi Y, Watanabe M. A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. J Gastroenterol. 2013;48:595–600.PubMedCrossRef
348.
Binitha MP, Sarita SP, Manju M. Photoletter to the editor: Squamous cell carcinoma associated with and masquerading as molluscum contagiosum. J Dermatol Case Rep. 2013;7:103–5.PubMedPubMedCentralCrossRef
349.
Rajagopal R, Arora PN, Ramasastry CV, Kar PK. Skin changes in internal malignancy. Indian J Dermatol Venereol Leprol. 2004;70:221–5.PubMed
350.
351.
Okamoto S, Hata A, Sadaoka K, Yamanishi K, Mori Y. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis. 2009;200:1606–10.PubMedCrossRef
352.
Mahajan S, Koranne R, Sharma S. Cutaneous manifestation of diabetes melitus. Indian J Dermatol Venereol Leprol. 2003;69:105–8.PubMed
353.
Yang YW, Chen YH, Lin HW. Risk of herpes zoster among patients with psychiatric diseases: a population-based study. J Eur Acad Dermatol Venereol. 2011;25:447–53.PubMedCrossRef
354.
Lee JY, Yoon NH, Park SD. A clinical study of the nature of pain associated with herpes zoster. Korean J Dermatol. 2006;44:1298–303.
355.
Yang YD, Wu JJ, Bi JJ, Lu YG, Zhu TY. Retrospective study of the characteristics of postherpetic neuralgia in 178 cases. Chin J Clin Rehab. 2005;9:23–5.
356.
357.
Cho SI, Lee CH, Park GH, Park CW, Kim HO. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study. J Pain. 2014;15:149–56.PubMedCrossRef
358.
Zhu SM, Liu YM, An ED, Chen QL. Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia. J Zhejiang Univ Sci B. 2009;10:625–30.PubMedPubMedCentralCrossRef
359.
Imafuku S, Nakayama J, Higa K, Furue M, Takahara M, Katayama I, et al. One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study). J Eur Acad Dermatol Venereol. 2014;28:1716–22.PubMedCrossRef
360.
Kanbayashi Y, Onishi K, Fukazawa K, Okamoto K, Ueno H, Takagi T, et al. Predictive factors for postherpetic neuralgia using ordered logistic regression analysis. Clin J Pain. 2012;28:712–14.PubMedCrossRef
361.
Zhang DP, He L. Risk factors and prevention measures of postherpetic neuralgia. Chin J Clin Rehab. 2005;9:118–9.
362.
Nithyanandam S, Dabir S, Stephen J, Joseph M. Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia. Int J Dermatol. 2009;48:484–7.PubMedCrossRef
363.
Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain. 2013;26:21–6.PubMedPubMedCentralCrossRef
364.
Chen JY, Lan KM, Sheu MJ, Tseng SF, Weng SF, Hu ML. Peptic ulcer as a risk factor for postherpetic neuralgia in adult patients with herpes zoster. J Med Virol. 2015;87:222–9.PubMedCrossRef
365.
Sumiyama D, Kikkawa EF, Kita YF, Shinagawa H, Mabuchi T, Ozawa A, et al. HLA alleles are associated with postherpetic neuralgia but not with herpes zoster. Tokai J Exp Clin Med. 2008;33:150–3.PubMed
366.
Sato M, Ohashi J, Tsuchiya N, Kashiwase K, Ishikawa Y, Arita H, et al. Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes Immun. 2002;3:477–81.PubMedCrossRef
367.
Ozawa A, Sasao Y, Iwashita K, Miyahara M, Sugai J, Iizuka M, et al. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN). Tissue Antigens. 1999;53:263–8.PubMedCrossRef
368.
Sato-Takeda M, Ihn H, Ohashi J, Tsuchiya N, Satake M, Arita H, et al. The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain. 2004;110:329–36.PubMedCrossRef
369.
Kirizume K, Imataki O, Shintani T, Fujihara S, Waki F, Ohue Y, et al. Aggravated post-herpetic neuralgia due to bortezomib. Rinsho Ketsueki. 2008;49:331–4.PubMed
370.
Choi WS, Kwon SS, Lee J, Choi SM, Lee JS, Eom JS, et al. Immunity and the burden of herpes zoster. J Med Virol. 2014;86:525–30.PubMedCrossRef
371.
Mehta J, Mahajan V, Khanna S. Disseminated zoster with polyneuritis cranialis and motor radiculopathy: Letter to editor. Neurol India. 2002;50:228–9.PubMed
372.
Kim SH, Suh MK. The clinical features of herpes zoster ophthalmicus in inpatients. Korean J Dermatol. 2008;46:1337–43.
373.
Ando K, Kohmoto H. Clinical features of herpes zoster ophthalmicus. Jpn J Clin Ophthalmol. 2000;54:385–7.
374.
Amaki S, Suzuki S, Shinbo R, Ando R, Oguchi Y, Shimizu H, et al. A statistical study of ocular complications of herpes zoster ophthalmicus and its prolongation factors. Nihon Ganka Gakkai Zasshi. 1995;99:289–95.PubMed
375.
Yoshida M, Hayasaka S, Yamada T, Yanagisawa S, Hayasaka Y, Nakamura N, et al. Ocular findings in Japanese patients with varicella-zoster virus infection. Ophthalmologica. 2005;219:272–5.PubMedCrossRef
376.
Kimata N, Nakagawa H, Araki H. Clinical features of herpes zoster keratitis. Jpn J Clin Ophthalmol. 1996;50:1113–6.
377.
Matsuda A, Tagawa Y, Abe N, Tsuda K, Matsuda H. Classification of corneal complications from varicella zoster virus. Jpn J Clin Ophthalmol. 1995;49:1519–23.
378.
McDonald EM, Patel DV, McGhee CN. A prospective study of the clinical characteristics of patients with herpes simplex and varicella zoster keratitis, presenting to a New Zealand emergency eye clinic. Cornea. 2015;34:279–84.PubMedCrossRef
379.
Zheng Y, Shi J. Clinical analysis of 58 cases of herpetic keratouveitis. Chin Ophthalmic Res. 2009;27:809–11.
380.
Thean JH, Hall AJ, Stawell RJ. Uveitis in Herpes zoster ophthalmicus. Clin Experiment Ophthalmol. 2001;29:406–10.PubMedCrossRef
381.
Hanajiri M, Matsumoto T, Hatano H, Ohno S. Herpes zoster ophthalmicus without skin eruptions. Jpn J Clin Ophthalmol. 1994;48:658–60.
382.
Kwok SK, Ho PCP, Chau GKO. Herpes zoster ophthalmicus - A family physician’s perspective. Hong Kong Pract. 2001;23:57–62.
383.
Albietz JM, Lenton LM. Late reactivation of herpes zoster keratitis results in band keratopathy. Optom Vis Sci. 2014;91:e149–55.PubMedCrossRef
384.
Cao L. Ophthalmic symptoms in AIDS. Int J Ophthalmol. 2009;9:393–4.
385.
Nithyanandam S, Joseph M, Stephen J. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients. Int J STD AIDS. 2013;24:106–9.PubMedCrossRef
386.
Gupta N, Sachdev R, Sinha R, Titiyal JS, Tandon R. Herpes zoster ophthalmicus: disease spectrum in young adults. Middle East Afr J Ophthalmol. 2011;18:178–82.PubMedPubMedCentralCrossRef
387.
Babu K, Kini R, Philips M, Subbakrishna DK. Clinical profile of isolated viral anterior uveitis in a South Indian patient population. Ocul Immunol Inflamm. 2014;22:356–9.PubMedCrossRef
388.
Ichikawa T, Sakai J, Yamauchi Y, Minoda H, Usui M. A study of 44 patients with Kirisawa type uveitis. Nihon Ganka Gakkai Zasshi. 1997;101:243–7.PubMed
389.
Tan WJ, Poh EW, Wong PY, Ho SL, Lim WK, Teoh SC. Trends in patterns of anterior uveitis in a tertiary institution in Singapore. Ocul Immunol Inflamm. 2013;21:270–5.PubMedCrossRef
390.
Wang TJ, Hu CC, Lin HC. Increased risk of anterior uveitis following herpes zoster: a nationwide population-based study. Arch Ophthalmol. 2012;130:451–5.PubMedCrossRef
391.
Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: A case series with clinical features and treatment outcomes. Clin Exp Ophthalmol. 2009;37:473–7.PubMedCrossRef
392.
Roy R, Pal BP, Mathur G, Rao C, Das D, Biswas J. Acute retinal necrosis: clinical features, management and outcomes–a 10 year consecutive case series. Ocul Immunol Inflamm. 2014;22:170–4.PubMedCrossRef
393.
Sodeyama H, Todokoro D, Yamada N, Kishi S. Identification of causative virus and clinical course of acute retinal necrosis. Jpn J Clin Ophthalmol. 2014;68:947–52.
394.
Itoh N, Matsumura N, Ogi A, Nishide T, Imai Y, Kanai H, et al. High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. Am J Ophthalmol. 2000;129:404–5.PubMedCrossRef
395.
Grover R, Ratho RK, Gupta V, Mahajan RC, Gupta A. Role of viral serology in the diagnosis of acute retinal necrosis syndrome. Ind J Pathol Microbiol. 2002;45:269–71.
396.
Madhavan HN. Laboratory investigations on viral and Chlamydia trachomatis infections of the eye: Sankara Nethralaya experiences. Indian J Ophthalmol. 1999;47:241–6.PubMed
397.
Mizuuchi K, Namba K, Kotake S, Ohno S. Clinical features of acute retinal necrosis at Hokkaido University Hospital. Nihon Ganka Gakkai Zasshi. 2008;112:136–40.PubMed
398.
Shimakawa M, Sato N. A case of AIDS complicated by progressive outer retinal necrosis. Nihon Ganka Gakkai Zasshi. 1999;103:137–43.PubMed
399.
Sittivarakul W, Aui-aree N. Clinical features, management and outcomes of progressive outer retinal necrosis (PORN) in southern Thailand. J Med Assoc Thai. 2009;92:360–6.PubMed
400.
Oshitari K, Arimoto H, Suzuki S, Oguchi Y. Rapidly progressive outer retinal necrosis in a patient with acquired immunodeficiency syndrome. Nihon Ganka Gakkai Zasshi. 1994;98:1141–6.PubMed
401.
Gill H, Cheung J, Wong I, Lie AK, Kwong YL. Varicella zoster virus progressive outer retinal necrosis after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2012;157:279.PubMedCrossRef
402.
Kim SJ, Park SJ, Yu HG, Kim NJ, Jang HC, Oh MD. Ocular manifestations of acquired immunodeficiency syndrome in Korea. J Korean Med Sci. 2012;27:542–6.PubMedPubMedCentralCrossRef
403.
Lim WK, Chee SP, Nussenblatt RB. Progression of varicella-zoster virus necrotizing retinopathy in an HIV-negative patient with transient immune deviation. Graefes Arch Clin Exp Ophthalmol. 2005;243:607–9.PubMedCrossRef
404.
Tseng CC, Chen SN, Hwang JF, Lin CJ, Chen HS. Progressive outer retinal necrosis associated with occlusive vasculitis in acquired immunodeficiency syndrome. J Formos Med Assoc. 2015;114:469–72.PubMedCrossRef
405.
Inoue Y, Takano M, Kawai H, Ichibe Y, Shimizu K. Progressive outer retinal necrosis in a patient with interstitial nephritis. Jpn J Clin Ophthalmol. 2006;60:1087–90.
406.
Miyaoka Y, Suzuki J, Yamauchi Y, Goto H. A bilateral case of progressive outer retinal necrosis with retinal detachment resistant to antiviral treatments. Jpn J Clin Ophthalmol. 2008;62:489–92.
407.
Ozaki H, Jane H, Inoue H, Kozawa M, Kondo H, Uchio E. Outcome of treatment for acute retinal necrosis. Jpn J Clin Ophthalmol. 2011;65:1819–25.
408.
Hong J. Discuss on the diagnosis and treatment of viral cornea endotheliitis. Ophthalmol China. 2010;19:158–60.
409.
Wang AG, Liu JH, Hsu WM, Lee AF, Yen MY. Optic neuritis in herpes zoster ophthalmicus. Jpn J Ophthalmol. 2000;44:550–4.PubMedCrossRef
410.
Menon V, Kumar G, Tandon R. Optic neuropathy secondary to herpes zoster ophthalmicus. Indian J Ophthalmol. 1995;43:78–9.PubMed
411.
Suraiya MS, Norazlina B, Carmen C, Muhaya M. Bilateral optic neuritis in pregnancy. Med J Malaysia. 2003;58:771–3.PubMed
412.
Obata H, Yamagami S, Saito S, Sakai O, Tsuru T. A case of acute dacryoadenitis associated with herpes zoster ophthalmicus. Jpn J Ophthalmol. 2003;47:107–9.PubMedCrossRef
413.
Yokoyama C, Mori S, Kamada A, Kase S, Ishida S. A case of herpes zoster ophthalmicus with acute dacryoadenitis as the initial manifestation. Jpn J Clin Ophthalmol. 2011;65:945–8.
414.
Yong VK, Yip CC, Yong VS. Herpes zoster ophthalmicus and the superior orbital fissure syndrome. Singapore Med J. 2001;42:485–6.PubMed
415.
Bourke RD, Pyle J. Herpes zoster ophthalmicus and the orbital apex syndrome. Aust New Zealand J Ophthalmol. 1994;22:77–80.CrossRef
416.
Saxena R, Phuljhele S, Aalok L, Sinha A, Menon V, Sharma P, et al. A rare case of orbital apex syndrome with herpes zoster ophthalmicus in a human immunodeficiency virus-positive patient. Indian J Ophthalmol. 2010;58:527–30.PubMedPubMedCentralCrossRef
417.
Biswas J, Deka S, Padmaja S, Madhavan HN, Kumarasamy N, Solomon S. Central retinal vein occlusion due to herpes zoster as the initial presenting sign in a patient with acquired immunodeficiency syndrome (AIDS). Ocul Immunol Inflamm. 2001;9:125–30.PubMedCrossRef
418.
Min SU, Li K, Won CH, Cho S, Huh CH, Kim BJ, et al. Clinical analysis of Ramsay Hunt syndrome. Korean J Dermatol. 2007;45:1121–6.
419.
420.
Murakami S, Hato N, Horiuchi J, Miyamoto Y, Aono H, Honda N, et al. Clinical features and prognosis of facial palsy and hearing loss in patients with Ramsay Hunt syndrome. J Otolaryngol Jpn. 1996;99:1772–9.
421.
Ou CY, Chao WY. Herpes zoster oticus. J Otolaryngol Soc Repub China. 1997;32:379–85.
422.
Hung CW, Wang SJ, Chen SP, Lirng JF, Fuh JL. Trigeminal herpes zoster and Ramsay Hunt syndrome with a lesion in the spinal trigeminal nucleus and tract. J Neurol. 2010;257:1045–46.PubMedCrossRef
423.
McCullough MJ, Savage NW. Oral viral infections and the therapeutic use of antiviral agents in dentistry. Aust Dent J. 2005;50 Suppl 2:S31–5.PubMedCrossRef
424.
Sengoku R, Yaguchi H, Matsushima S, Mochio S. Zoster sine herpete: detection by skin exudates and contrast magnetic resonance imaging. Eur Neurol. 2012;67:154.PubMedCrossRef
425.
Lu YC, Young YH. Vertigo from herpes zoster oticus: superior or inferior vestibular nerve origin? Laryngoscope. 2003;113:307–11.PubMedCrossRef
426.
Isawa M. Unilateral deafness and vestibular dysfunction caused by herpes zoster virus. Otolaryngol Head Neck Surg Tokyo. 2001;73:938–41.
427.
Shim HJ, Jung H, Park DC, Lee JH, Yeo SG. Ramsay Hunt syndrome with multicranial nerve involvement. Acta Oto-Laryngol. 2011;131:210–5.CrossRef
428.
Lee HH, Huang LK, Hu CJ, Chen CC. Atypical Ramsay Hunt syndrome. Acta Neurol Taiwan. 2014;23:80–1.PubMed
429.
Miyazaki Y, Tajima Y, Sudo K, Matsumoto A, Kikuchi S, Tashiro K. A case of Ramsay Hunt syndrome initiated with hoarseness and dysphagia: Consideration on spreading mechanisms of cranial neuropathy. Clin Neurol. 2002;42:855–8.
430.
Choi HN, Kim JE, Chung DY, Park SY, Oh JH. Herpes zoster oticus with cranial polyneuropathy without involvement of facial nerve. Korean J Audiol. 2011;15:155–8.
431.
Sun WL, Yan JL, Chen LL. Ramsay Hunt syndrome with unilateral polyneuropathy involving cranial nerves V, VII, VIII, and XII in a diabetic patient. Quintessence Int. 2011;42:873–7.PubMed
432.
Sakane S, Enomoto H, Tamaki N, Oridate N. Cases of laryngeal paralysis caused by the varicella-zoster virus (VZV). Pract Oto-Rhino-Laryngol. 2014;107:399–404.CrossRef
433.
Kato T. Vocal cord paralysis caused by varicella zoster virus. Otolaryngol Head Neck Surg Tokyo. 2005;77:389–91.
434.
Wu CL, Linne OC, Chiang CW. Herpes zoster laryngis with prelaryngeal skin erythema. Ann Otol Rhinol Laryngol. 2004;113:113–4.PubMedCrossRef
435.
Morinaka S. Herpes zoster laryngitis with intractable hiccups. Auris Nasus Larynx. 2009;36:606–8.PubMedCrossRef
436.
Tamakawa S, Takada M. A case of herpes zoster affecting the glossopharyngeal nerve. J Anesth. 1999;13:230–2.PubMedCrossRef
437.
Ling B, Novakovic D, Sulica L. Cough after laryngeal herpes zoster: a new aspect of post-herpetic sensory disturbance. J Laryngol Otol. 2014;128:209–11.PubMedCrossRef
438.
Yoshida T, Fujisaki N, Nakachi R, Sueyoshi T, Suwazono S, Suehara M. Persistent hiccups and vomiting with multiple cranial nerve palsy in a case of zoster sine herpete. Intern Med. 2014;53:2373–6.PubMedCrossRef
439.
440.
Ono N, Sakabe A, Nakajima M. Herpes zoster oticus-associated jugular foramen syndrome. Brain Nerve. 2010;62:81–4.PubMed
441.
Fang CW, Lin CC. Ramsay Hunt syndrome with hemiparesis and hemihypoesthesia: report of 2 cases. Acta Neurol Taiwan. 2009;18:276–80.PubMed
442.
Furuta Y, Ohtani F, Kawabata H, Fukuda S, Bergström T. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis. 2000;30:529–33.PubMedCrossRef
443.
Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope. 2007;117:147–56.PubMedCrossRef
444.
Terada K, Niizuma T, Kawano S, Kataoka N, Akisada T, Orita Y. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol. 1998;56:359–63.PubMedCrossRef
445.
Takahash K, Aono T, Shichinohe M, Tamura M, Iwata Y, Yamanishi K, et al. Herpesvirus DNA in peripheral blood mononuclear cells of some patients with Meniere's disease. Microbiol Immunol. 2001;45:635–8.PubMedCrossRef
446.
Yazawa Y, Suzuki M, Hanamitsu M, Kimura H, Tooyama I. Detection of viral DNA in the endolymphatic sac in Ménière's disease by in situ hybridization. ORL J Otorhinolaryngol Relat Spec. 2003;65:162–8.PubMedCrossRef
447.
448.
Son HH, Sim HS, Lee SK. Clinical study of motor paresis in in-patients with herpes zoster. Korean J Dermatol. 2011;49:961–8.
449.
Gopal KVT, Sarvani D, Krishnam Raju PV, Rao GR, Venkateswarlu K. Herpes zoster motor neuropathy: A clinical and electrophysiological study. Indian J Dermatol Venereol Leprol. 2010;76:569–71.PubMedCrossRef
450.
Takahashi T, Tamura M, Miki K, Yamaguchi M, Kanno A, Nunomura S, et al. Varicella zoster virus myelitis in two elderly patients: diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens. Case Rep Neurol. 2013;5:81–90.PubMedPubMedCentralCrossRef
451.
Liu W, Zhu YY, Jiang FX, He J, Hu B. A case of systemic lupus erythematosus with herpes zoster myelitis. J Clin Dermatol. 2013;42:412–3.
452.
Ong OL, Churchyard AC, New PW. The importance of early diagnosis of herpes zoster myelitis. Med J Aust. 2010;193:546–7.PubMed
453.
Mehndiratta MM, Bansal J, Gupta M, Puri V. Herpes zoster cervical myelitis in an immunocompetent subject. Neurol India. 2000;48:189–90.PubMed
454.
455.
Tak WJ, Chong YS, Seo SJ, Hong CK. A case of motor paralysis caused by herpes zoster. Korean J Dermatol. 2002;40:1157–60.
456.
Shin SJ, Yoo CS, Kil MS, Kim CW, Kim SS. A case of motor paralysis of the limb caused by herpes zoster. Korean J Dermatol. 2012;50:621–3.
457.
Fujimoto S, Matsuno O, Matsumoto T, Kumamoto T, Tsuda T. A case of diaphragmatic paralysis following herpes zoster. Clin Neurol. 1996;36:345–7.
458.
Her Y, Kim CW, Kim SS. A clinical study of motor involvement by herpes zoster. Korean J Dermatol. 2010;48:468–73.
459.
Lee CC, Wu JC, Huang WC, Shih YH, Cheng H. Herpes zoster cervical myelitis in a young adult. J Chin Med Assoc. 2010;73:605–10.PubMedCrossRef
460.
Hosaka A, Nakamagoe K, Watanabe M, Tamaoka A. Magnetic resonance images of herpes zoster myelitis presenting with Brown-Séquard syndrome. Arch Neurol. 2010;67:506.PubMedCrossRef
461.
Lee MH, Song JH, Lee DI, Ahn HS, Park JW, Cha YD. Newly developed urinary retention and motor weakness of lower extremities in a postherpetic neuralgia patient. Korean J Pain. 2013;26:76–9.PubMedPubMedCentralCrossRef
462.
Tseng YH. Acute orbital myositis heralding herpes zoster ophthalmicus: report of a case. Acta Neurol Taiwan. 2008;17:47–9.PubMed
463.
Kang JH, Sheu JJ, Lin HC. Increased risk of Guillain-Barré Syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis. 2010;51:525–30.PubMedCrossRef
464.
Wakasugi K, Imaizumi T, Nishimura Y, Fujimoto H, Ayabe M, Shoji H, et al. Guillain-Barré syndrome associated with herpes zoster. Intern Med. 2001;40:552.PubMedCrossRef
465.
Nagane Y, Utsugisawa K, Obara D. A case of herpes zoster associated Guillain-Barré syndrome with a relapse of eruptions after intravenous immunoglobulin therapy. Clin Neurol. 2006;46:664–7.
466.
Sheu JJ, Keller JJ, Lin HC. Increased risk of cancer after Bell's palsy: a 5-year follow-up study. J Neurooncol. 2012;110:215–20.PubMedCrossRef
467.
Sanjay S, Chan EW, Gopal L, Hegde SR, Chang BC. Complete unilateral ophthalmoplegia in herpes zoster ophthalmicus. J Neuroophthalmol. 2009;29:325–37.PubMedCrossRef
468.
Shin HM, Lew H, Yun YS. A case of complete ophthalmoplegia in herpes zoster ophthalmicus. Korean J Ophthalmol. 2005;19:302–4.PubMedCrossRef
469.
Sato R, Yamada M, Tamai K. Total ophthalmoplegia in a case of herpes zoster ophthalmicus. Jpn J Clin Ophthalmol. 2008;62:1279–83.
470.
Im M, Kim BJ, Seo YJ, Park JK, Lee JH. Complete ophthalmoplegia after herpes zoster. Clin Exp Dermatol. 2007;32:162–4.PubMedCrossRef
471.
Nakazawa T, Omura M, Sugita R. A case of herpes zoster ophthalmicus with total ophthalmoplegia. Jpn J Clin Ophthalmol. 1998;52:1933–7.
472.
Ying XH, Wagle AM, Tan L, Sanjay S, Hedge SR, Chew YC, et al. A rare case of herpes zoster ophthalmicus with complete ophthalmoplegia. J Am Geriatr Soc. 2008;56:2160–2.PubMedCrossRef
473.
Jang SJ, Choe YB, Ahn KJ. A Case of motor paralysis caused by herpes zoster. Korean J Dermatol. 2004;42:236–8.
474.
Tam TC, Chan KY, Ho SL, Luk JK, Chu LW. Herpetic shoulder paresis in a Chinese elderly patient. Hong Kong Med J. 2005;11:399–402.PubMed
475.
Kang SH, Song HK, Jang Y. Zoster-associated segmental paresis in a patient with cervical spinal stenosis. J Int Med Res. 2013;41:907–13.PubMedCrossRef
476.
Siddalingappa K, Lokanatha K. Segmental motor paralysis of the right upper limb in herpes zoster. Indian J Dermatol Venereol Leprol. 2006;72:252.CrossRef
477.
Wu CM, Hsu CY, Shie HH. Herpes zoster motor neuropathy in an elderly man. Eur Geriatr Med. 2014;5:216–7.CrossRef
478.
Kawajiri S, Tani M, Noda K, Fujishima K, Hattori N, Okuma Y. Segmental zoster paresis of limbs: report of three cases and review of literature. Neurologist. 2007;13:313–7.PubMedCrossRef
479.
Namekawa M, Kameda T, Kumabe A, Mise J. Segmental zoster paresis of the right shoulder. Intern Med. 2013;52:2839.PubMedCrossRef
480.
Fabian VA, Wood B, Crowley P, Kakulas BA. Herpes zoster brachial plexus neuritis. Clin Neuropathol. 1997;16:61–4.PubMed
481.
Choi JY, Kang CH, Kim BJ, Park KW, Yu SW. Brachial plexopathy following herpes zoster infection: two cases with MRI findings. J Neurol Sci. 2009;285:224–6.PubMedCrossRef
482.
Bessho M, Nakajima H, Ito T, Kitaoka H. A case of incomplete Brown-Séquard syndrome after thoracic herpes zoster infection. Clin Neurol. 2010;50:175–89.
483.
Seo DH, Lee SJ, Hyun JK, Kim TU. A case of herpes zoster peripheral polyneuropathy manifested by foot drop in chronic myeloid leukemia. Ann Rehabil Med. 2012;36:724–8.PubMedPubMedCentralCrossRef
484.
Kim JB, Jung HJ, Lee JM, Im KS, Joo CH, Kim JW. Disseminated herpes zoster with a zoster paresis-induced femoral fracture. Geriatr Gerontol Int. 2012;12:168–71.PubMedCrossRef
485.
Kim SY, Hwang KE, Jung JH, Park JH, Kim HJ, Kim HR, et al. Diaphragmatic paralysis following cervical herpes zoster. Tuberc Respir Dis. 2006;61:80–2.CrossRef
486.
Koh YM, Baik JJ, Woo SI, Park KW, Chung Y. Diaphragmatic paralysis induced by herpes zoster. Tuberc Respir Dis. 1996;43:92–5.CrossRef
487.
Lin CM, Shieh WB, Chiang PC, Shieh MG, Liu YC, Chiou CC, et al. An unusual cause of dyspnea in a patient with cervical herpes zoster. J Clin Neurosci. 2012;19:608–9.PubMedCrossRef
488.
489.
Lee UH, Park HS, Choi JC, Chun DK. A case of abdominal protrusion caused by herpes zoster. Korean J Dermatol. 2004;42:659–61.
490.
Chang TCC, Chin YY, Lan CCE. Herpes zoster with autonomic dysregulation presented as alteration in local microcirculation: A case report. Dermatol Sin. 2011;29:72–4.CrossRef
491.
Sharma PK, Gautam RK, Basistha C, Jain RK, Kar HK. Abdominal hernia following abdominal herpes zoster. Indian J Dermatol Venereol Leprol. 2001;67:39–40.PubMed
492.
Tashiro S, Akaboshi K, Kobayashi Y, Mori T, Nagata M, Liu M. Herpes zoster-induced trunk muscle paresis presenting with abdominal wall pseudohernia, scoliosis, and gait disturbance and its rehabilitation: a case report. Arch Phys Med Rehabil. 2010;91:321–5.PubMedCrossRef
493.
Kim ED, Kang BG, Kim JH, Roh M, Jo DH. Abdominal distention and constipation followed by herpes zoster infection. Korean J Anesthesiol. 2013;65 Suppl 6:S143–4.PubMedPubMedCentralCrossRef
494.
Maeda K, Furukawa K, Sanada M, Kawai H, Yasuda H. Constipation and segmental abdominal paresis followed by herpes zoster. Intern Med. 2007;46:148–8.
495.
Kim JH, Lee SH, Na GJ, Lee SJ, Jo YG, Lee TH, et al. A rare case of Ogilvie syndrome associated with herpes zoster. Intest Res. 2012;10:379–82.CrossRef
496.
Hiramatsu S, Nebiki H, Ueno A, Wakahara Y, Maruyama H, Suekane T, et al. A case of paralytic ileus associated with varicella zoster virus infection. Nihon Shokakibyo Gakkai Zasshi. 2013;110:1007–13.PubMed
497.
Imafuku S, Takahara M, Uenotsuchi T, Iwato K, Furue M. Herpes zoster-associated voiding dysfunction in hematopoietic malignancy patients. Int J Dermatol. 2008;47:36–9.PubMedCrossRef
498.
Chen PH, Hsueh HF, Hong CZ. Herpes zoster-associated voiding dysfunction: a retrospective study and literature review. Arch Phys Med Rehabil. 2002;83:1624–8.PubMedCrossRef
499.
Tsai HN, Wu WJ, Huang SP, Su CM, Chen CC, Wang CJ, et al. Herpes zoster induced neuropathic bladder–a case report. Kaohsiung J Med Sci. 2002;18:39–44.PubMed
500.
Hiraga A, Nagumo K, Sakakibara R, Kojima S, Fujinawa N, Hashimoto T. Loss of urinary voiding sensation due to herpes zoster. Neurourol Urodyn. 2003;22:335–7.PubMedCrossRef
501.
Matsuo T, Oba K, Miyata Y, Igawa T, Sakai H. Four cases of urinary dysfunction associated with sacral herpes zoster. Acta Urol Jpn. 2014;60:87–90.
502.
Addison B, Harvey M. Herpes zoster-induced acute urinary retention. Emerg Med Australas. 2013;25:279–81.PubMedCrossRef
503.
Yamanishi T, Yasuda K, Sakakibara R, Hattori T, Uchiyama T, Minamide M, et al. Urinary retention due to herpes virus infections. Neurourol Urodyn. 1998;17:613–9.PubMedCrossRef
504.
Fukao M, Isogai R, Kawada A, Shimizu N, Matsumoto S. Herpes zoster associated with bladder/rectum symptom. Skin Res. 2005;4:386–9.
505.
Matsumoto H, Shimizu T, Tokushige S, Mizuno H, Igeta Y, Hashida H. Rectal ulcer in a patient with VZV sacral meningoradiculitis (Elsberg syndrome). Intern Med. 2012;51:651–4.PubMedCrossRef
506.
Chen JH, Chen KY. Acute sciatica in a patient with herpes zoster infection. Acta Clin Belg. 2011;66:70–1.PubMedCrossRef
507.
Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443–8.PubMedCrossRef
508.
Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–7.PubMedCrossRef
509.
Chen WH, Chui C, Yin HL. Zoster sine herpete, vertebral artery stenosis, and ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22:e234–7.PubMedCrossRef
510.
511.
Hoshino S, Hayashi A, Yoshizawa T, Tamaoka A, Shoji S. A case of delayed cerebral infarction occurring in puerperium preceded by herpes zoster ophthalmicus in late pregnancy. No To Shinkei. 1999;51:529–33.PubMed
512.
Kim MJ, Lee KO, Lee KY, Oh SH, Na SJ, Yoon B, et al. Hemichorea caused by intracranial hemorrhage following contralateral herpes zoster ophthalmicus. J Clin Neurosci. 2013;20:738–9.PubMedCrossRef
513.
Song HJ, Hong WK, Lee HS, Choi GS, Shin JH. Herpes zoster complicated by delayed intracranial haemorrhage. Clin Exp Dermatol. 2009;34:518–9.PubMedCrossRef
514.
Verma R, Singh D, Sharma P. Contralateral stroke with rapid recovery in a patient of herpes zoster ophthalmicus. Neurol Asia. 2011;16:247–50.
515.
Kalita J, Das M, Misra UK. Herpes zoster ophthalmicus leading to middle cerebral artery infarction: A case report. Int J Angiol. 2004;13:51–3.CrossRef
516.
Fukutake T, Hatakeyama H, Shinotoh H, Hattori T. Herpes zoster ophthalmicus and delayed contralateral hemiparesis: a case of ipsilateral midbrain involvement. Eur Neurol. 1998;40:57–8.PubMed
517.
Lee SJ, Lee DG. Isolated gait ataxia as a sole manifestation of right lateral medullary infarct following ipsilateral trigeminal herpes zoster. Case Rep Neurol. 2014;6:193–6.PubMedPubMedCentralCrossRef
518.
Yasuda C, Okada K, Ohnari N, Akamatsu N, Tsuji S. Cerebral infarction and intracranial aneurysm related to the reactivation of varicella zoster virus in a Japanese acquired immunodeficiency syndrome (AIDS) patient. Clin Neurol. 2013;53:701–5.
519.
Bhat G, Mathur DS, Saxena GN, Jain S, Singh AP, Bhaduria D. Granulomatous angiitis of the central nervous system associated with herpes zoster. J Assoc Physicians India. 2002;50:977–8.PubMed
520.
Vibha D, Prabhakar S, Khurana D, Khandelwal N. Varicella zoster vasculopathy presenting as lateral medullary syndrome. J Neurovirol. 2012;18:538–40.PubMedCrossRef
521.
Nagafuchi M, Nagafuchi Y, Sato R, Imaizumi T, Ayabe M, Shoji H, et al. Adult meningism and viral meningitis, 1997–2004: Clinical data and cerebrospinal fluid cytokines. Intern Med. 2006;45:1209–12.PubMedCrossRef
522.
Fujita H, Kurokawa S, Imaizumi S, Kawasaki H, Harada K. Two cases of meningitis developed while undergoing therapy for herpes zoster. Nishinihon J Dermatol. 1994;56:992–5.CrossRef
523.
Takeshima S, Neshige S, Himeno T, Hara N, Yoshimoto T, Takamatsu K, et al. Clinical, epidemiological, and etiological studies of aseptic meningitis in adults. Clin Neurol. 2014;54:791–7.
524.
Choi R, Kim GM, Jo IJ, Sim MS, Song KJ, Kim BJ, et al. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis. J Med Virol. 2014;86:957–62.PubMedCrossRef
525.
Srivastava T, Nagpal K. Herpes zoster meningoencephalitis complicated with peripheral vascular disease: an uncommon presentation of a common disease. Scand J Infect Dis. 2014;46:716–8.PubMedCrossRef
526.
Ohtomo R, Shirota Y, Iwata A, Shimizu J, Tsuji S. Cerebral microbleeding in varicella-zoster viral meningitis: an early sign of vasculopathy? Neurology. 2014;82:814–5.PubMedCrossRef
527.
528.
Saxena A, Khiangte B, Tiewsoh I, Jajoo UN. Herpes zoster encephalitis presenting as multiple cerebral hemorrhages - a rare presentation: a case report. J Med Case Rep. 2013;7:155.PubMedPubMedCentralCrossRef
529.
Baek W, Lee SG, Kim YS, Kim JH, Jun JB, Kim HY. Fatal varicella-zoster virus vasculopathy associated with adalimumab therapy. Arch Neurol. 2012;69:1193–6.PubMedCrossRef
530.
Sasson SC, Oon A, Chagantri J, Brew BJ, Carr A. Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report. BMC Infect Dis. 2013;13:396.PubMedPubMedCentralCrossRef
531.
Wang L, Holthaus EA, Jimenez XF, Tavee J, Li Y. MRI evolution of CLIPPERS syndrome following herpes zoster infection. J Neurol Sci. 2015;348:277–8.PubMedCrossRef
532.
McKelvie PA, Collins S, Thyagarajan D, Trost N, Sheorey H, Byrne E. Meningoencephalomyelitis with vasculitis due to varicella zoster virus: a case report and review of the literature. Pathology. 2002;34:88–93.PubMedCrossRef
533.
Douglas A, Harris P, Francis F, Norton R. Herpes zoster meningoencephalitis: Not only a disease of the immunocompromised? Infection. 2010;38:73–5.PubMedCrossRef
534.
Sugisaki K, Yoshida H. Varicella zoster virus meningoencephalitis accompanied by sporadic skin lesions in an older immunocompetent adult. J Infect Chemother. 2007;13:270–2.PubMedCrossRef
535.
Chun WC, Kin MT, Wing KT, Tin CL, Wai KK. Hypoglycorrhachia in herpes zoster associated encephalitis of an immunocompetent young male: An unusual presentation. J Neurol. 2005;252:987–8.CrossRef
536.
Miyazaki Y, Riku Y, Goto Y, Mano K, Yoshida M, Hashizume Y. VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male. J Neurol Sci. 2008;275:42–5.PubMedCrossRef
537.
Byun JW, Song HJ, Choi GS, Shin JH. A clinical study on herpes zoster meningoencephalitis. Korean J Dermatol. 2011;49:328–33.
538.
Yoshifuku A, Ueki Y, Tamai M, Miyoshi H, Higashi Y, Kanekura T, et al. A case of herpes zoster associated with meningoencephalitis. Nishinihon J Dermatol. 2009;71:494–6.CrossRef
539.
Pandey PK, Garg D, Bhatia A, Jain V. Horner’s syndrome and sixth nerve palsy due to herpes zoster ophthalmicus arteritis. Eye. 2005;19:224–6.PubMedCrossRef
540.
Kobayashi Y, Yamamoto T. A case of Horner’s syndrome associated with ophthalmic herpes zoster. Clin Neurol. 2007;47:105–8.
541.
Tsuda H, Tanaka K. Internal carotid artery involvement in herpes zoster ophthalmicus. Intern Med. 2012;51:2067–8.PubMedCrossRef
542.
Nishitani M, Kodama T, Ohashi Y, Tatematsu Y, Maruo H. A case of cavernous sinus syndrome following herpes zoster ophthalmicus. Folia Ophthalmol Jpn. 2002;53:898–903.
543.
Cho BJ, Kim JS, Hwang JM. Horner’s syndrome and contralateral abducens nerve palsy associated with zoster meningitis. Korean J Ophthalmol. 2013;27:474–7.PubMedPubMedCentralCrossRef
544.
545.
Roberts TV, Francis IC, Kappagoda MB, Dick AD. Herpes zoster chorioretinopathy. Eye (Lond). 1995;9:594–8.CrossRef
546.
Wang CC, Lin CL, Chang YJ, Wang GJ, Sung FC, Kao CH. Herpes zoster infection associated with acute coronary syndrome: a population-based retrospective cohort study. Br J Dermatol. 2014;170:1122–9.PubMedCrossRef
547.
Wu PY, Lin CL, Sung FC, Chou TC, Lee YT. Increased risk of cardiovascular events in patients with herpes zoster: a population-based study. J Med Virol. 2014;86:772–7.PubMedCrossRef
548.
Maity PK, Chakrabarti N, Mondal M, Patar K, Mukhopadhyay M. Deep vein thrombosis: A rare signature of herpes zoster. J Assoc Physicians India. 2014;62:72–4.PubMed
549.
Kundu AK. Herpes zoster-induced myocarditis in a patient with diabetes mellitus. J Assoc Physicians India. 1999;47:286–7.
550.
Cheung MY, Viney M. A unique case of recurrent asystole secondary to paroxysmal pain of acute herpetic ophthalmicus. Anesth Analg. 2007;105:1127–9.PubMedCrossRef
551.
Kume T, Hirose M, Yamashita T, Mizuno S, Hosokawa T, Sekimoto M, et al. Analysis of blood pressure in elderly patients with postherpetic neuralgia. Pain Clinic. 2001;13:153–7.CrossRef
552.
Lee HW, Kim KJ, Chang SE, Lee MW, Choi JH, Moon KC, et al. A case of generalized herpes zoster associated with herpetic folliculitis and syringitis. Korean J Dermatol. 2005;43:274–6.
553.
Park JS, Ryu H, Ha SH, Park HS, Lee J, Son SJ. Two cases of herpetic syringitis. Korean J Dermatol. 2002;40:1449–51.
554.
Tanaka A, Hayaishi N, Kondo Y, Kurachi K, Tanemura A, Katayama I. Severe gangrene accompanied by varicella zoster virus-related vasculitis mimicking rheumatoid vasculitis. Case Rep Dermatol. 2014;6:103–7.PubMedPubMedCentralCrossRef
555.
556.
Baek JH, Hong KC, Lee DY, Kim MS, Lee UH, Park HS. Alopecia areata associated with Herpes zoster. J Dermatol. 2013;40:672.PubMedCrossRef
557.
Garg P, Mathur U, Athmanathan S, Rao GN. Treatment outcome of Moraxella keratitis: our experience with 18 cases–a retrospective review. Cornea. 1999;18:176–81.PubMedCrossRef
558.
Yang SC, Ho HC, Lay CJ, Tsai CC. Aspergillus invasive otitis externa as a complication of herpes zoster oticus. Tzu Chi Med J. 2011;23:28–30.CrossRef
559.
Seo JK, Lee SM, Lee SK. Clinical observation of bacterial studies in the skin lesions of patients with herpes zoster. Korean J Dermatol. 2007;45:1031–40.
560.
Yamada Y, Ito R, Bito M, Tashima S, Sakamoto K, Konishi K. A case of subcutaneous abscess at the site of herpes zoster in a patient with poorly controlled diabetes. Skin Res. 2014;13:13–5.
561.
Jarrett P, Ha T, Oliver F. Necrotizing fasciitis complicating disseminated cutaneous herpes zoster. Clin Exp Dermatol. 1998;23:87–8.PubMedCrossRef
562.
563.
Gupta S, Gupta S, Thomas M, Mahendra A, Jindal N, Bhaskar G, et al. Herpes Zoster with disseminated lesions. What is it? J Med Life. 2013;6:84–5.PubMedPubMedCentral
564.
Garg G, Thami GP. Psoriasis herpeticum due to varicella zoster virus: A Kaposi's varicelliform eruption in erythrodermic psoriasis. Indian J Dermatol. 2012;57:213–4.PubMedPubMedCentralCrossRef
565.
Gupta S. Many faces of Koebner phenomenon in psoriasis. Indian J Dermatol Venereol Leprol. 2002;68:222–4.PubMed
566.
Terao M, Tanemura A, Katayama I. Vitiligo exacerbated after herpes zoster. J Dermatol. 2012;39:938–9.PubMedCrossRef
567.
Huang CW, Tu ME, Wu YH, Lin YC. Isotopic response of fungal granuloma following facial herpes zoster infections - report of three cases. Int J Dermatol. 2007;46:1141–5.PubMedCrossRef
568.
Ghorpade A. Wolf’s isotopic response - Furuncles at the site of healed herpes zoster in an Indian male. Int J Dermatol. 2010;49:105–7.PubMedCrossRef
569.
Kim SM, Lee SY, Rhee CH, Lee JS, Yun SK, Kim HU, et al. A case of papular granuloma annulare occurring on the site of herpes zoster: Isotopic response. Korean J Dermatol. 2008;46:818–20.
570.
Ohata C, Shirabe H, Takagi K, Kawatsu T. Granuloma annulare in herpes zoster scars. J Dermatol. 2000;27:166–9.PubMedCrossRef
571.
Wang T, Liu YH, Zheng HY, Yu BT, Fang K. A case of nonspecific granulomatous perivasculitis on herpes zoster scars. J Clin Dermatol. 2010;39:163–4.
572.
Inaoka M, Kano Y, Horie C, Shiohara T. Cutaneous granulomatous reaction after herpes zoster in drug-induced hypersensitivity syndrome. Am J Dermatopathol. 2011;33:872–4.PubMedCrossRef
573.
Suh KS, Choi SY, Jeon YS, Sim HJ, Kim ST. A case of granuloma annulare occurring on herpes zoster. Korean J Dermatol. 2005;43:834–6.
574.
Chang SE, Bae GY, Moon KC, Do SH, Lim YJ. Subcutaneous granuloma annulare following herpes zoster. Int J Dermatol. 2004;43:298–9.PubMedCrossRef
575.
Ohmori S, Sugita K, Ikenouchi-Sugita A, Nakamura M. Erythema annulare centrifugum associated with herpes zoster. J UOEH. 2012;34:225–9.PubMedCrossRef
576.
Sugita K, Kabashima K, Tokura Y. Erythema annulare centrifugum associated with herpes zoster. Eur J Dermatol. 2008;18:205–6.PubMed
577.
Lee HW, Lee DK, Rhee DY, Chang SE, Choi JH, Moon KC, et al. Erythema annulare centrifugum following herpes zoster infection: Wolf’s isotopic response? Br J Dermatol. 2005;153:1241–3.PubMedCrossRef
578.
Onishi I, Kishimoto S. Erythema multiforme after resolution of herpes zoster by acyclovir. Eur J Dermatol. 2002;12:370–2.PubMed
579.
Kim JS, Kim MH, Choi HY, Myung KB. A Case of zosteriform lichen planus occurring on herpes zoster lesions. Korean J Dermatol. 2004;42:217–9.
580.
Choi HJ, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. A case of zosteriform lichen planus on the site of healed herpes zoster: Wolf’s isotopic response. Korean J Dermatol. 2004;42:456–9.
581.
582.
Qu T, Fang K. Bullous morphea arising at the site of a healed herpes zoster. J Dermatol. 2014;41:553–4.PubMedCrossRef
583.
Endo Y, Tanioka M, Tanizaki H, Mori M, Kawabata H, Miyachi Y. Bullous variant of Sweet's syndrome after herpes zoster virus infection. Case Rep Dermatol. 2011;3:259–62.PubMedPubMedCentralCrossRef
584.
Ghorpade AK. Reactive perforating collagenosis with a giant lesion at the site of healed herpes zoster. Indian J Dermatol Venereol Leprol. 2011;77:202–3.PubMedCrossRef
585.
Bang SW, Kim YK, Whang KU. Acquired reactive perforating collagenosis: unilateral umbilicated papules along the lesions of herpes zoster. J Am Acad Dermatol. 1997;36:778–9.PubMedCrossRef
586.
Lee HJ, Roh KY, Ha SJ, Kim JW. Pitted keratolysis of the palm arising after herpes zoster. Br J Dermatol. 1999;140:974–5.PubMedCrossRef
587.
588.
Watanabe D, Kuhara T, Ishida N, Tamada Y, Matsumoto Y. Sarcoid tissue reaction on herpes zoster scars in a myelodysplastic syndrome patient: Wolf's isotopic response. J Eur Acad Dermatol Venereol. 2009;23:475–7.PubMedCrossRef
589.
Verma KK, Mittal R. Cutaneous lesions of multicentric reticulohystiocytosis developing in herpes zoster lesions. Acta Derm Venereol. 2000;80:150.PubMedCrossRef
590.
Yamamoto T, Yokoyama A. Nodular solar degeneration following herpes zoster. Br J Dermatol. 1996;134:606.PubMedCrossRef
591.
Mittal RR, Singh SP, Gupta S, Sethi PS. Nodular colloid degeneration over herpes zoster scars. Indian J Dermatol Venereol Leprol. 1996;62:181–2.PubMed
592.
Kwon JI, Cho JW, Lee KS. A case of verrucous hyperplasia at the site of healed herpes zoster: Isotopic response. Korean J Dermatol. 2011;49:726–9.
593.
Kim MB, Jwa SW, Ko HC, Kim SJ, Kwon KS, Oh CH. A case of secondary cutaneous mucinosis following herpes zoster: Wolf’s isotopic response. Int J Dermatol. 2009;48:212–4.PubMedCrossRef
594.
Lee HJ, Ahn WK, Chae KS, Ha SJ, Kim JW. Localized chronic urticaria at the site of healed herpes zoster. Acta Derm Venereol. 1999;79:168.PubMedCrossRef
595.
De D, Dogra S, Kanwar AJ. Prurigo nodularis in healed herpes zoster scar: An isotopic response. J Eur Acad Dermatol Venereol. 2007;21:711–2.PubMed
596.
Lee YB, Park HJ, Lee JY, Cho BK. Two cases of chronic cutaneous graft-versus-host-reaction on the site of healed herpes zoster as an isotopic response. Korean J Dermatol. 2008;46:90–3.
597.
Matsumura T, Watanabe H, Batchelor J, Sueki H, Iijima M. Drug eruption caused by the nonionic contrast medium iohexol. Recall-like phenomenon' appearing on an area previously affected by herpes zoster. J Dermatol. 2006;33:705–8.PubMedCrossRef
598.
Na SY, Lee HY, Baek JO, Roh JY, Lee JR. A case of cutaneous zosteriform metastatic carcinoma arising on the healed site of herpes zoster. Korean J Dermatol. 2008;46:347–51.
599.
Hapgood G, Mooney E, Dinh HV, Gin D, McLean C, Ting SB. Leukaemia cutis in chronic lymphocytic leukaemia following varicella zoster virus reactivation. Intern Med J. 2012;42:1355–8.PubMedCrossRef
600.
Kim TH, Kim DH, Yeom JS, Lee GY, Kim WS, Kim KJ. A case of AIDS-associated Kaposi's sarcoma on the site of healed herpes zoster as an isotopic response. Korean J Dermatol. 2009;47:1172–6.
601.
Kim CY, Nam YH, Kim GD, Oh CW. Tufted angioma in site of healed herpes zoster: Isotopic response. Clin Exp Dermatol. 2006;31:714–5.PubMedCrossRef
602.
Siwamogstham P, Kuansuwan C, Reichart PA. Herpes zoster in HIV infection with osteonecrosis of the jaw and tooth exfoliation. Oral Dis. 2006;12:500–5.PubMedCrossRef
603.
Volvoikar P, Patil S, Dinkar A. Tooth exfoliation, osteonecrosis and neuralgia following herpes zoster of trigeminal nerve. Indian J Dent Res. 2002;13:11–4.PubMed
604.
Pillai KG, Nayar K, Rawal YB. Spontaneous tooth exfoliation, maxillary osteomyelitis and facial scarring following trigeminal herpes zoster infection. Prim Dent Care. 2006;13:114–6.PubMedCrossRef
605.
Jain MK, Manjunath KS, Jagadish SN. Unusual oral complications of herpes zoster infection: report of a case and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:e37–41.PubMedCrossRef
606.
Lambade P, Lambade D, Saha TK, Dolas RS, Pandilwar PK. Maxillary osteonecrosis and spontaneous teeth exfoliation following herpes zoster. Oral Maxillofac Surg. 2012;16:369–72.PubMedCrossRef
607.
Yamamoto K, Inagake K, Tatebayashi S, Yamakawa N, Inoue M, Yasumoto J, et al. Alveolar osteonecrosis of the mandible after varicella zoster infection of the trigeminal nerve. Asian J Oral Maxillofac Surg. 2004;16:204–8.CrossRef
608.
Badjate SJ, Cariappa KM, Shenoi SR, Nakhate S. Ramsay-Hunt syndrome complicating osteonecrosis of edentulous maxilla and mandible: report of a rare case. J Maxillofac Oral Surg. 2009;8:188–91.PubMedPubMedCentralCrossRef
609.
Pushpanshu K, Kaushik R, Srivastava S, Punyani SR. An unusual complication of tooth exfoliation and osteonecrosis following herpes zoster infection of trigeminal nerve: a case report and literature review. Minerva Stomatol. 2013;62:241–5.PubMed
610.
Mahima VG, Patil K, Srikanth HS. Herpes zoster induced alveolar necrosis in an immunocompetent patient. Iran J Clin Infect Dis. 2010;5:235–8.
611.
Liu YC, Yang YH, Hsiao HH, Yang WC, Liu TC, Chang CS, et al. Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan. BMC Cancer. 2012;12:503.PubMedPubMedCentralCrossRef
612.
Ho JD, Xirasagar S, Lin HC. Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. Ophthalmology. 2011;118:1076–81.PubMedCrossRef
613.
Yamamoto M, Mine H, Akazawa K, Maehara Y, Sugimachi K. Gastrointestinal cancer and herpes zoster in adults. Hepatogastroenterology. 2003;50:1043–6.PubMed
614.
Lin SY, Liu JH, Yeh HC, Lin CL, Tsai IJ, Chen PC, et al. Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis. 2014;33:1809–15.PubMedCrossRef
615.
Jiang ZM, Gao YH, Meng W, Wu WY, Jin L, Shen FM. The study on familial aggregation of systemic lupus erythematosus. Fudan Univ J Med Sci. 2005;32:270–4.
616.
Kang JH, Sheu JJ, Kao S, Lin HC. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J Infect Dis. 2011;204:188–92.PubMedCrossRef
617.
Tsai SY, Yang TY, Chen HJ, Chen CS, Lin WM, Shen WC, et al. Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study. Eur J Clin Microbiol Infect Dis. 2014;33:1653–9.PubMedCrossRef
618.
Chen MH, Wei HT, Su TP, Li CT, Lin WC, Chang WH, et al. Risk of depressive disorder among patients with herpes zoster: a nationwide population-based prospective study. Psychosom Med. 2014;76:285–91.PubMedCrossRef
619.
Wang X, Zhang L, Lei Y, Liu X, Zhou X, Liu Y, et al. Meta-analysis of infectious agents and depression. Sci Rep. 2014;4:4530.PubMed
620.
Chen YH, Chen YK, Keller JJ, Lin HC. A population-based case–control analysis of the association between herpes zoster and erectile dysfunction. J Infect. 2012;65:150–6.PubMedCrossRef
621.
622.
Wang YP, Liu CJ, Hu YW, Chen TJ, Lin YT, Fung CP. Risk of cancer among patients with herpes zoster infection: a population-based study. CMAJ. 2012;184:E804–9.PubMedPubMedCentralCrossRef
623.
Wang CC, Shiang JC, Chen JT, Lin SH. Syndrome of inappropriate secretion of antidiuretic hormone associated with localized herpes zoster ophthalmicus. J Gen Intern Med. 2011;26:216–20.PubMedCrossRef
624.
O'Rourke F, Chilov M. Localised herpes zoster infection and SIADH. Aust Fam Physician. 2006;35:789–90.PubMed
625.
Furuta E, Yasuda M, Yoshioka K, Isayama T, Nobunaga M. Syndrome of inappropriate secretion of antidiuretic hormone in elderly patients with rheumatoid arthritis associated with infections: Report of two cases. Intern Med. 1996;35:478–81.PubMedCrossRef
626.
Reid AB, Gome JJ. Localized herpes zoster infection causing the syndrome of inappropriate antidiuretic hormone secretion. Intern Med J. 2009;39:486–7.PubMedCrossRef
627.
Tsutsumi R, Adachi K, Yoshida Y, Yamamoto O. Drug-induced hypersensitivity syndrome in association with varicella. Acta Derm Venereol. 2015;95:503–4.PubMedCrossRef
628.
Tamayose K, Sugimoto K, Ando M, Oshimi K. Mononucleosis syndrome and acute monocytic leukemia. Eur J Haematol. 2002;68:236–8.PubMedCrossRef
629.
Eun YB, Bo KK, Seok GC, Jin WK. A case of disseminated herpes zoster with thrombocytopenia. Korean J Dermatol. 2005;43:410–12.
630.
Kawano N, Gondo H, Kamimura T, Aoki K, Iino T, Ishikawa F, et al. Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol. 2003;78:370–3.PubMedCrossRef
631.
Park BC, Choe YS, Kim DW, Lee WJ, Lee SJ, Na GY. Clinical study on dermatologic disease of the elderly. Korean J Dermatol. 2006;44:818–23.
632.
Furue M, Yamazaki S, Jimbow K, Tsuchida T, Amagai M, Tanaka T, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol. 2011;38:310–20.PubMedCrossRef
633.
Yoon NY, Hong SP, Jeon SY, Shin JS, Ahn SK. A clinical study of dermatologic diseases in elderly patients. Korean J Dermatol. 2011;49:887–95.
634.
Go JW, Cho HK, Kang WH, Ro BI. A statistical study of dermatoses in Goyang City (2004 ∼ 2008). Korean J Dermatol. 2009;47:896–903.
635.
Choi HS, Yun SK, Kim HU, Ihm CW. A statistical study of dermatoses in the Jeonbuk Province (1979–1980, 1987–2002). Korean J Dermatol. 2005;43:606–18.
636.
Hong S, Lee ES, Yoon KH. A statistical study of dermatoses in the Suwon area and southern area of Kyonggi (1995–2001). Korean J Dermatol. 2003;41:728–39.
637.
Shin BJ, Choe SW, Seo SJ, Hong CK. A clinical study of skin diseases in elderly patients(IV). Korean J Dermatol. 2002;40:1346–52.
638.
Wang E, Lim BL, Than KY. Dermatological conditions presenting at an emergency department in Singapore. Singapore Med J. 2009;50:881–4.PubMed
639.
Chan CY, Kam KL, Graham CA, Rainer TH, Luk NM. Clinical profile of skin diseases in accident and emergency department attenders. Hong Kong J Dermatol Venereol. 2007;15:4–9.
640.
Zhang Y, Zhou SX, Zhang TF, Huang GF. Analysis of the distribution of diseases in 6435 inpatients from the department of acupuncture and moxibustion. Zhongguo Zhen Jiu. 2011;31:941–4.PubMed
641.
Park EJ, Han KR, Kim DW, Kim C. A clinical survey of the patients in neuro-pain clinic at Ajou University. Korean J Pain. 2007;20:181–5.CrossRef
642.
643.
Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol. 2013;14:77–85.PubMedCrossRef
644.
Wehrhahn MC, Dwyer DE. Herpes zoster: Epidemiology, clinical features, treatment and prevention. Aust Prescr. 2012;35:143–7.CrossRef
645.
Cunningham AL, Litt J. Shingles: How to prevent it, how to treat it. Med Today. 2014;15:20–7.
646.
Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, et al. The prevention and management of herpes zoster. Med J Aust. 2008;188:171–6.PubMed
647.
Chopra A, Jassal JS, Bahl RK. Role of acyclovir and laser therapy in herpes zoster. Indian J Dermatol Venereol Leprol. 1994;60:208–9.
648.
Hayashibe K, Ichihashi M. Efficacy of acyclovir 400 mg tablet (Zovirax® tablet 400) in herpes zoster. Skin Res. 1994;36:543–50.
649.
Sugiyama Y, Tamura T, Seguchi T, Yoshida M, Tezuka T. Evaluation of efficacy of oral acyclovir in herpes zoster Trial of 2400 mg 3 times daily. Skin Res. 1994;36:459–64.
650.
Yoshikawa K, Doi T. Clinical evaluation of Zovirax® (acyclovir) tablet 400 on herpes zoster. Skin Res. 1994;36:441–58.
651.
Chen YH. Observation of oral acyclovir combined with sodium hyaluronate and fluorometholone eye drops on the treatment of herpes zoster keratitis. Intern Eye Sci. 2014;14:729–30.
652.
McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther. 2012;17:255–64.PubMedCrossRef
653.
Lin WR, Lin HH, Lee SS, Tsai HC, Huang CK, Wann SR, et al. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. J Microbiol Immunol Infect. 2001;34:138–42.PubMed
654.
Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect. 2004;37:75–81.PubMed
655.
Chen A, Sun X. Comparative study of treatment of herpes zoster with valaciclovir and acyclovir. Med J Wuhan Univ. 2006;27:537–8.
656.
Gopal MG, Shannoma, Sharath Kumar BC, Ramesh M, Nandini AS, Manjunath NC. A comparative study to evaluate the efficacy and safety of acyclovir and famciclovir in the management of herpes zoster. J Clin Diagn Res. 2013;7:2904–7.PubMedPubMedCentral
657.
Liao R, Wu J, Yang H. Contrast of acycloguanosine, famciclovir, ribavirin in treatment of herps zoster pruritus. Chin J Clin Rehab. 2003;7:904–5.
658.
Li W, Guo ZP, Xiong L. Domestic penciclovir powder through injection for improving cutaneous deficiency and residual neuralgia in patients with herpes zoster: A randomized, double-blind and controlled trial. Chin J Clin Rehab. 2005;9:34–7.
659.
Sodhi PK, Ratan SK. A case of chronic renal dysfunction following treatment with oral acyclovir. Scand J Infect Dis. 2003;35:770–2.PubMedCrossRef
660.
Kitching AR, Fagg D, Hay NM, Hatfield PJ, Macdonald A. Neurotoxicity associated with acyclovir in end stage renal failure. New Zealand Med J. 1997;110:167–9.PubMed
661.
Takayanagi A, Maehana T, Kyoda Y, Yanase M. Neurotoxicity of valacyclovir in a peritoneal dialysis patient. Hinyokika Kiyo. 2010;56:617–9.PubMed
662.
Asahi T, Tsutsui M, Wakasugi M, Tange D, Takahashi C, Tokui K, et al. Valacyclovir neurotoxicity: clinical experience and review of the literature. Eur J Neurol. 2009;16:457–60.PubMedCrossRef
663.
Yang HH, Hsiao YP, Shih HC, Yang JH. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient. Int J Dermatol. 2007;46:883–4.PubMedCrossRef
664.
Fujii H, Tanioka M, Matsumura Y, Miyachi Y, Matsubara T. A case of valaciclovir induced encephalopathy in a patient with peritoneal dialysis. Skin Res. 2007;6:372–5.
665.
Sagawa N, Tsurutani Y, Nomura K, Okuyama T, Kondo M, Sata A, et al. Acyclovir-Induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: Report of a case. Nihon Ronen Igakkai Zasshi. 2014;51:581–5.PubMedCrossRef
666.
Ng HW, Pang CT. Confusion in patients with shingles and renal failure: Acyclovir neurotoxicity or herpes encephalitis. Hong Kong J Emerg Med. 2012;19:205–9.
667.
Matsumoto R, Yoshida T, Tabata KI, Nakagawa SI, Yanagisawa N. A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster. Clin Neurol. 1996;36:590–3.
668.
Mihara A, Mori T, Nakazato T, Ikeda Y, Okamoto S. Acute renal failure caused by intravenous acyclovir for disseminated varicella zoster virus infection. Scand J Infect Dis. 2007;39:94–5.PubMedCrossRef
669.
Yamamoto Y, Suganuma A, Mishima N, Horibe C, Saito Y. A case of acute renal failure due to valacyclovir in an elderly patient with progressive supranuclear palsy. IRYO Jpn J Natl Med Serv. 2009;63:735–9.
670.
Kusakari Y, Tanita M, Egawa T, Yoshida H, Shingou T, Nakamura K, et al. Efficacy and safety of famciclovir for the treatment of herpes zoster patients with renal dysfunction. Nishinihon J Dermatol. 2014;76:44–51.CrossRef
671.
Yoon H, Rhew KY. Famciclovir as an antiviral agent for a patient with acute renal failure. Int J Clin Pharm. 2013;35:173–5.PubMedCrossRef
672.
Okamoto S, Ishibashi Y, Inoue Y, Uchio E, Ohashi Y, Kitagawa K, et al. Multicentered survey of ocular complications of acyclovir ophthalmic ointment. Jpn J Clin Ophthalmol. 1997;51:1112–4.
673.
Zhang JS. Clinical effect comparison of ganciclovir ophthalmic gel and ganciclovir eye drops in the treatment of herpes zoster keratitis. Int J Ophthalmol. 2011;11:309–10.
674.
Li SQ, Jia J, Zhang ZY. Clinical observation on eyelid herpes zoster with external use ganciclovir ophthalmic gel. Intern Eye Sci. 2014;14:1356–7.
675.
Nakamura H, Ishimoto S, Fujisawa K, Okada T, Tahara Y, Nakamura T, et al. Systemic ganciclovir with vitrectomy was effective in two cases of acute retinal necrosis. Jpn J Clin Ophthalmol. 1999;53:1599–603.
676.
Lee MY, Kim KS, Lee WK. Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus. Ocul Immunol Inflamm. 2011;19:212–3.PubMedCrossRef
677.
Hwangbo H, Jung SW, Son HH, Lee SK. Comparison between famciclovir and valacyclovir for the treatment of herpes zoster in adults. Korean J Dermatol. 2014;52:720–7.
678.
Ono F, Yasumoto S, Furumura M, Hamada T, Ishii N, Gyotoku T, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J Dermatol. 2012;39:902–8.PubMedCrossRef
679.
Bodsworth NJ, Boag F, Burdge D, Généreux M, Borleffs JC, Evans BA, et al. Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group. J Infect Dis. 1997;176:103–11.PubMedCrossRef
680.
Watabe T, Okuda H, Ogura K. Lethal drug interactions of the new antiviral, sorivudine, with anticancer prodrugs of 5-fluorouracil. Yakugaku Zasshi. 1997;117:910–21.PubMed
681.
Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866.
682.
Liu G, Zhan H, Deng R. A clinical study of 32 Hunt syndrome. Acta Acad Med Hubei. 1996;17:73.
683.
Ho KY, Pasutharnchat K. Intrathecal dexamethasone for the treatment of intractable postherpetic neuralgia: A case report. Internet J Pain Symptom Control Palliative Care. 2009;6:4.
684.
Achar A, Chakraborty PP, Bisai S, Biswas A, Guharay T. Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia. Acta Dermatovenerol Croat. 2012;20:89–94.PubMed
685.
Wrigley P, Cousins M. Postherpetic neuralgia: An update on management and prevention. Med Today. 2008;9:36–44.
686.
Kochar DK, Agarwal RP, Joshi A, Kumawat BL. Herpes zoster and post-herpetic neuralgia – a clinical trial of aspirin in chloroform for anodyne. J Assoc Physicians India. 1998;46:337–40.PubMed
687.
688.
Kanodia SK, Seth AK, Dixit AM. Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients. Indian J Dermatol. 2012;57:362–5.PubMedPubMedCentralCrossRef
689.
Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26–35.PubMedCrossRef
690.
Meng FY, Zhang LC, Liu Y, Pan LH, Zhu M, Li CL, et al. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a meta-analysis of randomized controlled trials. Minerva Anestesiol. 2014;80:556–7.PubMed
691.
Doggrell SA. Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opin Pharmacother. 2005;6:2535–9.PubMedCrossRef
692.
Zhang LX, Li GL. Effect of oxycodone-acetaminophen therapy in patients with intractable postherpetic neuralgia. Chin J New Drugs. 2009;18:427–8.
693.
Zhao G, Zhang H. Analgesic effect of oxycodone-acetaminophen tablets on herpes zoster. Chin J New Drugs. 2009;18:720–1.
694.
Liu GH, Liu JM. Efficacy of oxycodone-acetamainophen on postherpetic neuralgia in patients with zoster. Chin J New Drugs. 2009;18:722–3. 740.
695.
Wu XM, Zhu SM. Effect of oxycodone-acetaminophen in 58 patients with herpes zoster. Chin J New Drugs. 2009;18:718–9. 721.
696.
Yang Y, Yan JQ, Guo QL, Chen ZG. Safety and efficacy of oral oxycodone-acetaminophen versus tramadol in treatment of postherpetic neuralgia. Chin J New Drugs. 2009;18:527–9.
697.
Lin PL, Fan SZ, Huang CH, Huang HH, Tsai MC, Lin CJ, et al. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study. Reg Anesth Pain Med. 2008;33:320–5.PubMed
698.
Garnock-Jones KP, Keating GM. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia. Drugs. 2009;69:2149–65.PubMedCrossRef
699.
Iseki M, Mitsuhata H, Miyazaki T, Toriumi E, Yoshino K. Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream. Jpn J Anesthesiol. 2000;49:1204–9.
700.
Cousins MJ, Pickthorn K, Huang S, Critchley L, Bell G. The safety and efficacy of KAI-1678– an inhibitor of epsilon protein kinase C (εPKC)–versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design. Pain Med. 2013;14:533–40.PubMedCrossRef
701.
Chen SM, Chen JT, Kuan TS, Hong CZ. Myofascial trigger points in intercostal muscles secondary to herpes zoster infection of the intercostal nerve. Arch Phys Med Rehabil. 1998;79:336–8.PubMedCrossRef
702.
Xiao LZ, Zhang DR, Jiang J, Zhang KL, Zhang M, Zhu HQ. Feasibility of transdermal fentanyl for pain relief of herpes zoster and postherpetic neuralgia. Chin J Clin Rehab. 2004;8:216–7.
703.
Lee GY. The effect of fentanyl patch in the treatment of intractable postherpetic neuralgia. Korean J Dermatol. 2007;45:422–8.
704.
Guo WJ, Xiao ZY, Yang YX. Effectiveness of transdermal fentanyl combined with clodine for pain control of acute herpes zoster. J Dalian Med Univ. 2007;29:255–6.
705.
Pan BC, Hou XW, Li XP. Curative effect of recombinant human interferon α2b gel combined with aciclovir on herpes zoster. Chin J Biol. 2008;21:711–2.
706.
Miyoshi H, Hirotsuji N, Kino T, Katsu K. Interferon alpha gel for herpes zoster. Dermatology. 1997;194:306.PubMedCrossRef
707.
Akimoto T. Clinical evaluation of 3% Ara-A ointment on herpes zoster and herpes simplex. Skin Res. 1995;37:164–79.
708.
Ishii N, Baba N, Nakajima H, Yoshida S, Katoh Y. Clinical studies of Arasena-A® ointment I Clinical effects on herpes zoster. Skin Res. 1994;36:220–7.
709.
710.
Sun W, Xiang X, Zeng X. Compound ribavirin paint: Preparation and application. Chin Pharm J (China). 1996;31:150–3.
711.
712.
Kanai A, Osawa S, Suzuki A, Ishimaru R, Hoka S. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. Pain Med. 2007;8:36–40.PubMedCrossRef
713.
Kanai A, Wang G, Hoshi K, Okamoto H. Effects of intravenous prostaglandin E1 on pain and body temperature in patients with post-herpetic neuralgia. Pain Med (USA). 2010;11:609–16.CrossRef
714.
Lu YG, Wu JJ, Yang YD. Study of efficacy of Lipo PGE1 in treatment of postherpetic neuralgia in patients with herpes zoster. Chin J Clin Rehab. 2002;6:3092–3.
715.
Kushida Y, Yoshida M, Akaike Y, Yamada K, Nishizuka K, Kita M, et al. The effects of Lipo-PGE1 on shooting pain of postherpetic neuralgia. Hokuriku J Anesthesiol. 1999;33:59–62.
716.
Fujii K, Kanno Y, Konishi K, Ohgou N. A specific thrombin inhibitor, argatroban, alleviates herpes zoster-associated pain. J Dermatol. 2001;28:200–7.PubMedCrossRef
717.
Komori M, Fukuuchi A, Mae T, Nishiyama K, Kawamata M, Ozaki M. Milnacipran hydrochloride for the treatment of postherpetic neuralgia. Pain Clinic. 2006;18:421–3.CrossRef
718.
Sekiguchi T, Fujihara K, Sato H. Clinical effects of immunoglobulin (Polyglobin® N) for severe infectious disorders in dermatology. Jpn Pharmacol Ther. 1995;23:195–208.
719.
Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med. 2013;14:884–94.PubMedCrossRef
720.
Han G, Kim SH, Lee KS, Cho JW. Effect of botulinum toxin a on acute and chronic pain in herpes zoster patients. Korean J Dermatol. 2014;52:845–50.
721.
Zacest A, Anderson VC, Burchiel KJ. The glass half empty or half full – how effective are long-term intrathecal opioids in post-herpetic neuralgia? A case series and review of the literature. Neuromodulation. 2009;12:219–23.PubMedCrossRef
722.
Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009;109:1651–5.PubMedCrossRef
723.
Ji CM, Li XM, Sun DH, Jiang CL, Li SL. Clinical study on stellate ganglion block combined with pregabalin for treating postherpetic neuralgia at chest and back. Chin J New Drugs. 2012;21:1503–6.
724.
Wang JS. The comparison of therapeutic effect of three methods for the treatment of acute herpes zoster. Curr Opin Clin Exp Res. 2002;4:12–5.
725.
Manabe H, Dan K, Hirata K, Hori K, Shono S, Tateshi S, et al. Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain. Clin J Pain. 2004;20:302–8.PubMedCrossRef
726.
Bhargava R, Bhargava S, Haldia KN, Bhargava P. Jaipur block in postherpetic neuralgia. Int J Dermatol. 1998;37:465–8.PubMedCrossRef
727.
Puri N. Modified Jaipur block for the treatment of post-herpetic neuralgia. Int J Dermatol. 2011;50:1417–20.PubMedCrossRef
728.
Chaturvedi A, Dash HH. Sympathetic blockade for the relief of chronic pain. J Indian Med Assoc. 2001;99:698–703.PubMed
729.
Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH. The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol. 1999;135:1359–64.PubMedCrossRef
730.
Ahn HJ, Lim HK, Lee YB, Hwang SM, Lee WS, Ahn SK, et al. The effects of famciclovir and epidural block in the treatment of herpes zoster. J Dermatol. 2001;28:208–16.PubMedCrossRef
731.
Ahn SY, Lee YB, Lee KH, Lim HK, Lee WS, Ahn SK, et al. The effect of stellate ganglion block on herpes zoster. Korean J Dermatol. 2006;44:681–7.
732.
Jun JH, Ro YS, Kim JH, Shim JC. The effects of continuous epidural blockade in the treatment of postherpetic neuralgia. Korean J Dermatol. 1998;36:584–8.
733.
Koh WS, Park SM, Kim BS, Shin DY. The effect of sympathetic blocks in the prevention of postherpetic neuralgia. Korean J Dermatol. 1997;35:620–6.
734.
Shin HY, Kim DS, Kim SS. Superficial cervical plexus block for management of herpes zoster neuralgia in the C3 dermatome: a case report. J Med Case Rep. 2014;8:59.PubMedPubMedCentralCrossRef
735.
Lee JY, Sim WS, Kim KM, Oh MS, Lee JE. The effect of ketamine as an additive in epidural block on the intractable herpetic neuralgia: a case report. Korean J Anesthesiol. 2014;66:64–6.PubMedPubMedCentralCrossRef
736.
Chau SW, Soo LY, Lu DV, Chen TI, Cheng KI, Chu KS. Clinical experience of pain treatment for postherpetic neuralgia in elderly patients. Acta Anaesthesiol Taiwan. 2007;45:95–101.PubMed
737.
Dan K. Nerve block therapy and postherpetic neuralgia. Crit Rev Phys Rehabil Med. 1995;7:93–112.CrossRef
738.
Higa K, Hori K, Harasawa I, Hirata K, Dan K. High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: Comparison with effects of stellate ganglion block. Reg Anesth. 1998;23:25–9.
739.
Mizuno J, Sugimoto S, Ikeda M, Kamakura T, Machida K, Kusume S. Treatment with stellate ganglion block, continuous epidural block and ulnar nerve block of a patient with postherpetic neuralgia who developed complex regional pain syndrome (CRPS). Jpn J Anesthesiol. 2001;50:548–51.
740.
Tajima K, Iseki M, Inada E, Miyazaki T. The effects of early nerve blocks for prevention of postherpetic neuralgia and analysis of prognostic factors. Jpn J Anesthesiol. 2009;58:153–9.
741.
Tajima K, Kawagoe I, Kanai M, Mitsuhata H. Effective treatment of acute pain and related symptoms in elderly with herpes zoster. Jpn J Anesthesiol. 2008;57:874–8.
742.
Kishimoto N, Kato J, Suzuki T, Arakawa H, Ogawa S, Suzuki H. A case of RSD with complete disappearance of symptoms following intravenous ketamine infusion combined with stellate ganglion block and continuous epidural block. Jpn J Anesthesiol. 1995;44:1680–4.
743.
Tsai YC, Wang LK, Chen BS, Chen HP. Home-based patient-controlled epidural analgesia with bupivacaine for patients with intractable herpetic neuralgia. J Formos Med Assoc. 2000;99:659–62.PubMed
744.
Kang FC, Chang PJ, Chen HP, Tsai YC. Patient-controlled epidural analgesia for postherpetic neuralgia in an HIV-infected patient as a therapeutic ambulatory modality. Acta Anaesthesiol Sin. 1998;36:235–9.PubMed
745.
Okano K, Kondo H, Tsuchiya R, Naruke T, Sato M, Yokoyama R. Spinal epidural abscess associated with epidural catheterization: report of a case and a review of the literature. Jpn J Clin Oncol. 1999;29:49–52.PubMedCrossRef
746.
Taga K, Tomita M, Watanabe I, Sato K, Awamori K, Fujihara H, et al. Complete recovery of consciousness in a patient with decorticate rigidity following cardiac arrest after thoracic epidural injection. Br J Anaesth. 2000;85:632–4.PubMedCrossRef
747.
Iseki M, Okuno S, Tanabe Y, Mitsuhata H, Miyazaki T. Methicillin-resistant Staphylococcus aureus sepsis resulting from infection in paravertebral muscle after continuous epidural infusion for pain control in a patient with herpes zoster. Anesth Analg. 1998;87:116–8.PubMed
748.
Hamaguchi K, Ikegami S, Morita N, Fukushima H, Miyata K, Fujiki N, et al. A case of dyspnea caused by deep cervical hematoma following stellate ganglion block. Pract Oto-Rhino-Laryngol. 2007;100:391–5.CrossRef
749.
Miyamoto T, Nakatani T, Narai Y, Sakakibara M, Hashimoto T, Saito Y. A case of spinal epidural abscess after continuous epidural block to manage the pain of herpes zoster. Jpn J Anesthesiol. 2014;63:353–7.
750.
Son H, Sakuma Y, Kamada T, Kawano M, Suwa I, Kotani J, et al. A patient with respiratory arrest after stellate ganglion blockade. J Jpn Dent Soc Anesthesiol. 1996;24:489–92.
751.
Sugino N, Ohta A, Abe H, Mori H. Three cases of bacterial contaminations associated with epidural catheterization in patients of herpes zoster. Hokuriku J Anesthesiol. 1995;29:47–9.
752.
Suzuki T, Takemura H, Shida K, Higuchi H, Ohtsuka N, Masuda Y. The development of methicillin-resistant Staphylococcus aureus sepsis in a patient with herpes zoster during treatment with continuous epidural infusion. Jpn J Anesthesiol. 2002;51:293–5.
753.
Uematsu H, Hiei K, Kawasaki H. Unknown fever and abnormal liver functions after repeated epidural blocks with lidocaine for management of herpes zoster pain. Jpn J Anesthesiol. 1994;43:405–8.
754.
Wajima Z, Ishikawa G, Kaneko K, Inoue T, Ogawa R. A case of using continuous double-tapped epidural analgesia for herpes zoster duplex. Jpn J Anesthesiol. 1995;44:841–4.
755.
Jeon Y, Baek SU, Yeo JS. Spinal myoclonus developed during cervical epidural drug infusion in postherpetic neuralgia patient. Korean J Pain. 2011;24:169–71.PubMedPubMedCentralCrossRef
756.
Min BM, Kim JH. Epidural catheterization with a subcutaneous injection port for the long-term administration of opioids and local anesthetics to treat zoster-associated pain -a report of two cases-. Korean J Anesthesiol. 2013;65:462–7.PubMedPubMedCentralCrossRef
757.
Higa K, Shono S, Nitahara K. Postherpetic neuralgia. Jpn J Anesthesiol. 2010;59:1342–9.
758.
Moryama K. Effect of temporary spinal cord stimulation on postherpetic neuralgia in the thoracic nerve area. Neuromodulation. 2009;12:39–43.CrossRef
759.
Hirabayashi H, Kawata K, Hoshida T, Tamura K, Youngsu P, Nakase H. Neuromodulation therapy for neuropathic pain. Jpn J Neurosurg. 2011;20:93–102.
760.
Hijikata Y, Yamada S. Effect of Ganoderma lucidum on postherpetic neuralgia. Am J Chin Med. 1998;26:375–81.PubMedCrossRef
761.
Hijikata Y, Yasuhara A, Sahashi Y. Effect of an herbal formula containing Ganoderma lucidum on reduction of herpes zoster pain: a pilot clinical trial. Am J Chin Med. 2005;33:517–23.PubMedCrossRef
762.
Nakanishi M, Arimitsu J, Kageyama M, Otsuka S, Inoue T, Nishida S, et al. Efficacy of traditional Japanese herbal medicines-Keishikajutsubuto (TJ-18) and Bushi-matsu (TJ-3022)-against postherpetic neuralgia aggravated by self-reported cold stimulation: a case series. J Altern Complement Med. 2012;18:686–92.PubMedCrossRef
763.
Lee SM, Lim J, Lee JD, Choi DY, Lee S. Bee venom treatment for refractory postherpetic neuralgia: a case report. J Altern Complement Med. 2014;20:212–4.PubMedPubMedCentralCrossRef
764.
765.
Huang B, Zhou XY, Lu YP, Zhu ZF, Hou J, Sun JL, et al. Selective percutaneous dorsal root ganglion radiofrequency thermocoagulation guided by CT scanning in treatment of post-herpetic neuralgia. Nat Med J China. 2008;88:885–8.
766.
Lim SM, Park HL, Moon HY, Kang KH, Kang H, Baek CH, et al. Ultrasound-guided infraorbital nerve pulsed radiofrequency treatment for intractable postherpetic neuralgia - a case report -. Korean J Pain. 2013;26:84–8.PubMedPubMedCentralCrossRef
767.
Ko YK, Lee HY, Lee WY. Clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia. Korean J Pain. 2013;26:98–101.PubMedPubMedCentralCrossRef
768.
Chen HM. Zoster Chinese medicine treatment. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007;21:285–7.PubMed
769.
770.
Bourke A, Hui B. Weak evidence that HBOT is of benefit in the treatment of patients with herpes zoster. Diving Hyperbaric Med. 2013;43:174.
771.
772.
Fujiwara O, Mitamura Y, Ohtsuka K. Herpes zoster panuveitis progression despite acyclovir treatment in a patient following bone marrow transplantation. Jpn J Ophthalmol. 2005;49:536–8.PubMedCrossRef
773.
Abe T, Kuboki J, Tamai M. Sensitivity to acyclovir in acute retinal necrosis syndrome. Jpn J Clin Ophthalmol. 1997;51:1161–3.
774.
Leung AY, Chow HC, Kwok JS, Lui CK, Cheng VC, Yuen KY, et al. Safety of vaccinating sibling donors with live-attenuated varicella zoster vaccine before hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39:661–5.PubMedCrossRef
775.
Kanda Y, Mineishi S, Saito T, Saito A, Yamada S, Ohnishi M, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:689–92.PubMedCrossRef
776.
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, et al. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. Int J Infect Dis. 2014;19:26–32.PubMedCrossRef
777.
Uchiyama M, Tamai Y, Ikeda T. Low-dose acyclovir against reactivation of varicella zoster virus after unrelated cord blood transplantation. Int J Infect Dis. 2010;14:e451–2.PubMedCrossRef
778.
Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, et al. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2008;83:472–6.PubMedCrossRef
779.
Oshima K, Takahashi T, Mori T, Matsuyama T, Usuki K, Asano-Mori Y, et al. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group. Transpl Infect Dis. 2010;12:421–7.PubMedCrossRef
780.
Aoki T, Nishiyama T, Imahashi N, Kitamura K. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study. Jpn J Clin Oncol. 2011;41:876–81.PubMedCrossRef
781.
Fukushima T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, et al. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib. Anticancer Res. 2012;32:5437–40.PubMed
782.
Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant. 2000;25:657–64.PubMedCrossRef
783.
Takahashi M, Kamiya H, Asano Y, Shiraki K, Baba K, Otsuka T, et al. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. In: Gershon AA, Arvin AM, Calisher CH, editors. Archives of Virology, Supplement 17: Immunity to and prevention of herpes zoster. Vienna: Springer; 2001. p. 161–72. doi:10.​1007/​978-3-7091-6259-0_​17.CrossRef
784.
Takahashi M, Okada S, Miyagawa H, Amo K, Yoshikawa K, Asada H, et al. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine. 2003;21:3845–53.PubMedCrossRef
785.
Hata A, Inoue F, Yamasaki M, Fujikawa J, Kawasaki Y, Hamamoto Y, et al. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus. J Infect. 2013;67:215–9.PubMedCrossRef
786.
Marumoto T, Ono K. Varicella vaccine was effective in a case of recurrent ophthalmic zoster sine herpete. Jpn J Clin Ophthalmol. 2013;67:575–9.
787.
Sasadeusz J, Prince HM, Schwarer A, Szer J, Stork A, Bock HL, et al. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation. Transplant Infect Dis. 2014;16:1024–31.CrossRef
788.
Cheuk DK, Chiang AK, Lee TL, Chan GC, Ha SY. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. Cochrane Database Syst Rev. 2011;3:CD006505.
789.
Frazer IH, Levin MJ. Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer. Curr Opin Virol. 2011;1:268–79.PubMedPubMedCentralCrossRef
790.
791.
Recommended immunization schedule for adults in Korea, by the Korean Society of Infectious Diseases, 2012. Clin Exp Vaccine Res. 2014;3:110–2.
792.
793.
794.
795.
796.
Taiwan Association of Family Medicine. Clinical Handbook for Adult Immunization. 1st ed. Taipei: Taiwan Association of Family Medicine; 2010. p. 31–6.
797.
Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2011;3:CD007795.
798.
Loke XY, Tran W, Alderman CP. Survey of Australian inpatients on vaccination status and perceptions of influenza vaccination. Consult Pharm. 2012;27:553–63.PubMedCrossRef
799.
Macaladad N, Marcano T, Guzman M, Moya J, Jurado F, Thompson M, et al. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults. Vaccine. 2007;25:2139–44.PubMedCrossRef
800.
Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Centers for Disease Control and Prevention (CDC). Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63:729–31.PubMed
801.
Keating GM. Shingles (herpes zoster) vaccine (zostavax®): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years. Drugs. 2013;73:1227–44.PubMedCrossRef
802.
803.
804.
MacIntyre CR, Egerton T, McCaughey M, et al. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old. Hum Vaccin. 2010;6:894–902.
805.
Tseng HF, Smith N, Sy LS, Jacobsen SJ. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine. 2011;29:3628–32.PubMedCrossRef
806.
807.
MacIntyre R, Stein A, Harrison C, Britt H, Mahimbo A, Cunningham A, Thompson R. Increasing Trends of Herpes Zoster in Australia. PLoS One. 2015;10:e0125025.
Metadata
Title
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific
Authors
Liang-Kung Chen
Hidenori Arai
Liang-Yu Chen
Ming-Yueh Chou
Samsuridjal Djauzi
Birong Dong
Taro Kojima
Ki Tae Kwon
Hoe Nam Leong
Edward M. F. Leung
Chih-Kuang Liang
Xiaohong Liu
Dilip Mathai
Jiun Yit Pan
Li-Ning Peng
Eduardo Rommel S. Poblete
Philip J. H. Poi
Stewart Reid
Terapong Tantawichien
Chang Won Won
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2198-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue

Research article

Comparison of two commercial broad-range PCR and sequencing assays for identification of bacteria in culture-negative clinical samples

Research article

Development and validation of a prognostic score during tuberculosis treatment

Research article

Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples

Research article

Retesting and repeat positivity following diagnosis of Chlamydia trachomatis and Neisseria gonorrhoea in New Zealand: a retrospective cohort study

Research article

Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms

Research article

Assessing changes in knowledge, attitude and practices on dengue diagnosis and management among primary care physicians after the largest dengue epidemic in Singapore

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits